UO > About > Organizational Structure > Rectorate
Roman Hájek
Vice-Rector for Strategy and Development
| Academic degree, name, surname: | prof. MUDr. Roman Hájek, CSc. |
| Room, floor, building: |
R 204, Building R |
| Position: | Head of Department Vice-Rector |
| Research interests and teaching: | |
| Department (Faculty): |
Department of Haematooncology (Faculty of Medicine) Medical Research Center (Faculty of Medicine) University Offices |
| Phone number, mobile: |
+420 553 46 1013 +420 597 372 091 |
| E-mail: |
Another education, courses
2006
Prof. - Masaryk University, Brno, Czech Republic; Field of Study: Clinical Oncology
2001
Assoc Prof. - Department of Internal Medicine and Hemato-oncology, Masaryk University Hospital Brno, Czech Republic; Field of Study: Internal Medicine
1995
Ph.D. - Department of Internal Medicine and Hemato-oncology, Masaryk University Hospital Brno, Czech Republic; Field of Study: Hematooncology
1988
M.D. - Masaryk University, Brno, Czech Republic; Field of Study: General Medicine
Working Practice
Since 2015
Vice-Rector for Strategy and Development; University of Ostrava, Czech Republic
Since 2012
Head of Department of Clinical Hematooncology; University Hospital Ostrava, Czech Republic
2012 – 2014
Vice-dean for Science and Research; Faculty of Medicine, Ostrava University, Czech Republic
2011 – 2015
Project manager of Babak Myeloma Group; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
2010 – 2011
Director of Babak Research Institute; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
2007 – 2012
Vice-Director for Education and Research; University Hospital Brno, Brno, Czech Republic
Since 1999
Head of Laboratory of Experimental Hematology and Cell Immunotherapy; University Hospital Brno, Brno, Czech Republic
1989 – 2012
Physician; Department of Internal Medicine Hematooncology, University Hospital Brno, Brno, Czech Republic
Valuation
IMF Brian D. Novis research grant funded through the Black Swan Research Initiative
Membership
Since 2012
International Myeloma Society
Since 2009
European Hematology Association
Since 2008
International Myeloma Working Group
Since 2008
American Society of Hematology
Since 2007
Scientific Advisory Board of the International Myeloma Foundation
Since 2007
European Myeloma Network (Member of the Board since 2019)
Since 2005
Medical Advisory Board of Myeloma Euronet
Since 2001
Czech Myeloma Group Foundation, Chairman
Since 1996
Czech Myeloma Group, Chairman
Since 1994
Czech Society of Hematology and Oncology (Head of Myeloma Committee since 2006)
Research and professional experience
2001
Royal Prince Alfred Hospital of Hematooncology - Sydney, Austrálie
1998
Arkansas Myeloma Research Center, USA
1997
Arkansas Myeloma Research Center, USA
1996
ESO course Molecular Biology for Clinicians; Cambridge, United Kingdom
1995
Georgetown University Medical Center, WA, D. C., USA
| Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study | |
| Maria Gavriatopoulou, Meletios A. Dimopoulos, Hang Quach, Halyna Pylypenko, Roman Hájek, Xavier Leleu, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Reuben Benjamin, Mamta Krishnan Garg, Vadim Doronin, Yair Levy, Philippe Moreau, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Paul G. Richardson, Sebastian Grosicki ... other authors | |
| Year: 2022, American Journal of Hematology | |
| journal article | |
| Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6 | |
| Alyssa Clay-Gilmour, Subhayan Chattopadhyay, Michelle A. T. Hildebrandt, Hauke Thomsen, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus M. Nothen, Karl-Heinz Jockel, Borge Schmidt, Christian Langer, Roman Hájek, Goran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Florentin Spath, Richard Houlston, Hartmut Goldschmidt, Elisabet E. Manasanch, Aaron Norman, Shaji Kumar, S. Vincent Rajkumar, Susan Slager, Asta Forsti, Celine M. Vachon, Kari Hemminki ... other authors | |
| Year: 2022, Blood Cancer Journal | |
| journal article | |
| Limited efficacy of daratumumab in multiple myeloma with extramedullary disease | |
| Tomáš Jelínek, Tereza Ševčíková, David ŽIHALA, Tereza Popková, Veronika Kapustová, Lucie Broskevičová, Lenka Capkova, Lucie Rihova, Renata Bezdekova, Sabina Sevcikova, Vladimir Zidlik, Martin Havel, Hana Plonkova, Alexandra Jungova, Jiri Minarik, Martin Stork, Ludek Pour, Petr Pavlicek, Ivan Spicka, Vladimir Maisnar, Jakub Radocha, Michal Šimíček, Roman Hájek ... other authors | |
| Year: 2022, Leukemia | |
| journal article | |
| Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus | |
| C. Buske, M. Dreyling, A. Alvarez-Larrán, J. Apperley, L. Arcaini, C. Besson, L. Bullinger, P. Corradini, M. Giovanni Della Porta, M. Dimopoulos, S. D Sa, H.T. Eich, R. Fo?, P. Ghia, M.G. da Silva, J. Gribben, Roman Hájek, C. Harrison, M. Heuser, B. Kiesewetter, J.J. Kiladjian, N. Kröger, P. Moreau, J.R. Passweg, F. Peyvandi, D. Rea, J.-M. Ribera, T. Robak, J.F. San-Miguel, V. Santini, G. Sanz, P. Sonneveld, M. von Lilienfeld-Toal, C. Wendtner, G. Pentheroudakis, F. Passamonti ... other authors | |
| Year: 2022, ESMO Open | |
| journal article | |
| Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine | |
| Martina Zátopková, Tereza Ševčíková, Viola Fanfani, Zuzana Chyra, Lucie Rihova, Renata Bezdekova, David ŽIHALA, Kateřina Growková, Jana Filipová, Lucie Černá, Lucie Broskevicova, Fedor Kryukov, Jiri Minarik, Jana Smejkalova, Vladimir Maisnar, Lubica Harvanova, Ludek Pour, Alexandra Jungova, Tereza Popková, Julio Rodriguez Bago, Anjana Anilkumar Sithara, Matouš Hrdinka, Tomáš Jelínek, Michal Šimíček, Giovanni Stracquadanio, Roman Hájek ... other authors | |
| Year: 2022, Blood Advances | |
| journal article | |
| Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience | |
| Barbora Weinbergerova, Ivo Demel, Benjamin Visek, Jan Valka, Martin Cernan, Pavel Jindra, Jan Novak, Lukas Stejskal, Flora Kovacsova, Tomas Kabut, Tomas Szotkowski, Roman Hájek, Pavel Zak, Petr Cetkovsky, Zdenek Kral, Jiri Mayer ... other authors | |
| Year: 2022, Hematological Oncology | |
| journal article | |
| ANCHOR (OP-104): Melflufen Plus Dexamethasone and Bortezomib in Relapsed/Refractory Multiple Myeloma-Optimal Dose, Updated Efficacy and Safety Results | |
| Roman Hájek, Ludek Pour, Miquel Granell, Vladimir Maisnar, Paul Richardson, Stefan Norin, Malin Sydvander, Jakob Obermuller, Enrique Ocio ... other authors | |
| Year: 2021, American Journal of Hematology | |
| journal article | |
| Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data | |
| Viera Sandecka, Ludek Pour, Ivan Spicka, Jiri Minarik, Jakub Radocha, Tomáš Jelínek, Adriana Heindorfer, Petr Pavlicek, Michal Sykora, Alexandra Jungova, Petr Kessler, Marek Wrobel, David Starostka, Jana Ullrychova, Lukas Stejskal, Martin Stork, Jan Straub, Tomas Pika, Lucie Brozova, Sabina Sevcikova, Vladimir Maisnar, Roman Hájek ... other authors | |
| Year: 2021, European Journal of Haematology | |
| journal article | |
| COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network | |
| Heinz Ludwig, Pieter Sonneveld, Thierry Facon, Jesus San-Miguel, Herve Avet-Loiseau, Mohamad Mohty, Maria-Victoria Mateos, Philippe Moreau, Michele Cavo, Charlotte Pawlyn, Sonja Zweegman, Monika Engelhardt, Christoph Driessen, Gordon Cook, Melitios A. Dimopoulos, Francesca Gay, Hermann Einsele, Michel Delforge, Jo Caers, Katja Weisel, Graham Jackson, Laurent Garderet, Niels van de Donk, Xavier Leleu, Hartmut Goldschmidt, Meral Beksac, Inger Nijhof, Martin Schreder, Niels Abildgaard, Roman Hájek, Niklas Zojer, Efstathios Kastritis, Annemiek Broijl, Fredrik Schjesvold, Mario Boccadoro, Evangelos Terpos ... other authors | |
| Year: 2021, Lancet Haematology | |
| journal article | |
| Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients | |
| Gian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, Massimo Offidani, Paolo Corradini, Andrea Capra, Alessandra Romano, Anna Marina Liberati, Donato Mannina, Paolo de Fabritiis, Nicola Cascavilla, Marina Ruggeri, Roberto Mina, Francesca Patriarca, Giulia Benevolo, Angelo Belotti, Gianluca Gaidano, Arnon Nagler, Roman Hájek, Andrew Spencer, Pieter Sonneveld, Pellegrino Musto, Mario Boccadoro, Francesca Gay ... other authors | |
| Year: 2021, Clinical Cancer Research | |
| journal article | |
| Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma | |
| Holger W. Auner, Maria Gavriatopoulou, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Ludek Pour, Meletios A. Dimopoulos, Iryna Kriachok, Halyna Pylypenko, Xavier Leleu, Vadim Doronin, Ganna Usenko, Roman Hájek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don Ambrose Stevens, Hang Quach, Sundar Jagannath, Phillipe Moreau, Moshe Levy, Ashraf Badros, Larry D. Anderson Jr, Nizar J. Bahlis, Thierry Facon, Maria Victoria Mateos, Michele Cavo, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Paul G. Richardson, Sebastian Grosicki ... other authors | |
| Year: 2021, American Journal of Hematology | |
| journal article | |
| Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study | |
| Jacob P. Laubach, Fredrik Schjesvold, Mario Mariz, Meletios A. Dimopoulos, Ewa Lech-Maranda, Ivan Spicka, Vania T. M. Hungria, Tatiana Shelekhova, Andre Abdo, Lutz Jacobasch, Chantana Polprasert, Roman Hájek, Arpad Illes, Tomasz Wrobel, Anna Sureda, Meral Beksac, Iara Z. Goncalves, Joan Blade, S. Vincent Rajkumar, Ajai Chari, Sagar Lonial, Andrew Spencer, Pierre Maison-Blanche, Philippe Moreau, Jesus F. San-Miguel, Paul G. Richardson ... other authors | |
| Year: 2021, Lancet Oncology | |
| journal article | |
| Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations | |
| Laura Rosinol, Meral Beksac, Elena Zamagni, Niels W. C. J. Van de Donk, Kenneth C. Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios-Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernandez de Larrea, Gosta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kroeger, Robert A. Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria V. Mateos, Giampaolo Merlini, Mohamad Mohty, Philippe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson, Joan Blade ... other authors | |
| Year: 2021, British Journal of Haematology | |
| journal article | |
| Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2020 | |
| Ivo Demel, Julio Rodriguez Bago, Roman Hájek, Tomáš Jelínek | |
| Year: 2021, BRITISH JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis | |
| Zuzana Kufová, Tereza Ševčíková, Petr Vojta, J. Puterova, L. Brozova, Kateřina Growková, Jana Filipová, Martina Zátopková, S. Grosicki, A. Barchnicka, W. Wiktor-Jedrzejczak, A. Waszczuk-Gajda, A. Jungova, A. Mikulasova, M. Hajduch, M. Mokrejs, L. Pour, M. Stork, L. Harvanova, M. Mistrik, G. Mikala, P. Robak, A. Czyz, J. Debski, L. Usnarska-Zubkiewicz, A. Jurczyszyn, L. Stejskal, G. Morgan, Fedor Kryukov, E. Budinska, Michal Šimíček, Tomáš Jelínek, Matouš Hrdinka, Roman Hájek ... other authors | |
| Year: 2021, HAEMATOL-HEMATOL J | |
| journal article | |
| Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial | |
| Philippe Moreau, Meletios-Athanasios Dimopoulos, Joseph Mikhael, Kwee Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Spicka, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, Marie-Laure Risse, Gaelle Asset, Sandrine Mace, Thomas Martin ... other authors | |
| Year: 2021, Lancet | |
| journal article | |
| Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma | |
| Roman Hájek, Jiri Minarik, Jan Straub, Ludek Pour, Alexandra Jungova, Jesus G. Berdeja, Mario Boccadoro, Lucie Brozova, Andrew Spencer, Frits van Rhee, Jorge Vela-Ojeda, Michael A. Thompson, Rafat Abonour, Ajai Chari, Gordon Cook, Caitlin L. Costello, Faith E. Davies, Vania T. M. Hungria, Hans C. Lee, Xavier Leleu, Noemi Puig, Robert M. Rifkin, Evangelos Terpos, Saad Z. Usmani, Katja C. Weisel, Jeffrey A. Zonder, Magda Barinova, Matyas Kuhn, Jiri Silar, Lenka Capkova, Kenny Galvez, Jin Lu, Jennifer Elliott, Dawn Marie Stull, Kaili Ren, Vladimir Maisnar ... other authors | |
| Year: 2021, Future Oncology | |
| journal article | |
| Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life | |
| Evangelos Terpos, Joseph Mikhael, Roman Hájek, Ajai Chari, Sonja Zweegman, Hans C. Lee, Maria-Victoria Mateos, Alessandra Larocca, Karthik Ramasamy, Martin Kaiser, Gordon Cook, Katja C. Weisel, Caitlin L. Costello, Jennifer Elliott, Antonio Palumbo, Saad Z. Usmani ... other authors | |
| Year: 2021, Blood Cancer Journal | |
| journal article | |
| Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report | |
| David L. Murray, Noemi Puig, Sigurdur Kristinsson, Saad Z. Usmani, Angela Dispenzieri, Giada Bianchi, Shaji Kumar, Wee Joo Chng, Roman Hájek, Bruno Paiva, Anders Waage, S. Vincent Rajkumar, Brian Durie ... other authors | |
| Year: 2021, Blood Cancer Journal | |
| journal article | |
| Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial | |
| Stefania Oliva, Davine Hofste op Bruinink, Lucie Rihova, Mattia D Agostino, Lucia Pantani, Andrea Capra, Bronno van der Holt, Rossella Troia, Maria Teresa Petrucci, Tania Villanova, Pavla Vsianska, Romana Jugooa, Claudia Brandt-Hagens, Milena Gilestro, Massimo Offidani, Rossella Ribolla, Monica Galli, Roman Hájek, Francesca Gay, Michele Cavo, Paola Omede, Vincent H. J. van der Velden, Mario Boccadoro, Pieter Sonneveld ... other authors | |
| Year: 2021, Blood Cancer Journal | |
| journal article | |
| Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age > 80 in the IMWG frailty score | |
| Mattia D Agostino, Alessandra Larocca, Massimo Offidani, Anna Marina Liberati, Gianluca Gaidano, Maria Teresa Petrucci, Daniele Derudas, Andrea Capra, Renato Zambello, Nicola Cascavilla, Paolo de Fabritiis, Vanessa Innao, Francesca Bonello, Francesca Patriarca, Giulia Benevolo, Nicola Giuliani, Gabriele Aitoro, Tommasina Guglielmelli, Francesco Di Raimondo, Paolo Corradini, Roman Hájek, Pieter Sonneveld, Mario Boccadoro, Sara Bringhen ... other authors | |
| Year: 2021, Blood Cancer Journal | |
| journal article | |
| Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma | |
| Andrea Knight, Lucie Rihova, Romana Kralova, Miroslav Penka, Zdenek Adam, Ludek Pour, Martin Piskacek, Roman Hájek ... other authors | |
| Year: 2021, Journal of Clinical Medicine | |
| journal article | |
| Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders | |
| Jana Fečková Mihályová, Katarína Hradská, Tomáš Jelínek, Benjamin Motais, Piotr Celichowski, Roman Hájek ... other authors | |
| Year: 2021, International Journal of Molecular Sciences | |
| journal article | |
| Prvních 50 COVID-19 pozitivních pacientů na Klinice hematoonkologie Fakultní nemocnice Ostrava v roce 2020 | |
| O. Šušol, B. Hájková, Jana Fečková Mihályová, M. Kaščák, Juraj Ďuraš, J. Zuchnická, H. Plonková, K. Hradská, Tomáš Jelínek, Milan Navrátil, K. Benková, Lukáš Stejskal, Zdeněk Kořístek, T. Popková, D. Buffa, I. Demel, L. Muroňová, B. Dluhošová, L. Szeligová, L. Dudová, Hana Zelená, Jaromír Gumulec, Roman Hájek ... other authors | |
| Year: 2021, Transfuze a Hematologie Dnes | |
| journal article | |
| Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US | |
| Faith Davies, Robert Rifkin, Caitlin Costello, Gareth Morgan, Saad Usmani, Rafat Abonour, Antonio Palumbo, Dorothy Romanus, Roman Hájek, Evangelos Terpos, Dasha Cherepanov, Dawn Marie Stull, Hui Huang, Xavier Leleu, Jesus Berdeja, Hans C. Lee, Katja Weisel, Michael Thompson, Mario Boccadoro, Jeffrey Zonder, Gordon Cook, Noemi Puig, Jorge Vela-Ojeda, Eileen Farrelly, Aditya Raju, Marlo Blazer, Ajai Chari ... other authors | |
| Year: 2021, Annals of Hematology | |
| journal article | |
| Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network | |
| Heinz Ludwig, Mario Boccadoro, Philippe Moreau, Jesus San-Miguel, Michele Cavo, Charlotte Pawlyn, Sonja Zweegman, Thierry Facon, Christoph Driessen, Roman Hájek, Melitios A. Dimopoulos, Francesca Gay, Herve Avet-Loiseau, Evangelos Terpos, Niklas Zojer, Mohamad Mohty, Maria-Victoria Mateos, Hermann Einsele, Michel Delforge, Jo Caers, Katja Weisel, Graham Jackson, Laurent Garderet, Monika Engelhardt, Niels van de Donk, Xavier Leleu, Hartmut Goldschmidt, Meral Beksac, Inger Nijhof, Niels Abildgaard, Sara Bringhen, Pieter Sonneveld ... other authors | |
| Year: 2021, Leukemia | |
| journal article | |
| Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment | |
| Benjamin Motais, Sandra Charvátová, Zuzana Walek, Matouš Hrdinka, Ryszard Smolarczyk, Tomasz Cichoń, Justyna Czapla, Sebastian Giabel, Michal Šimíček, Tereza Ševčíková, Jiří Sobotka, Zdeněk Kořístek, Roman Hájek, Julio Rodriguez Bago ... other authors | |
| Year: 2021, Cells | |
| journal article | |
| Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk | |
| Shambavi Richard, Ajai Chari, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Ludek Pour, Iryna Kriachok, Meletios A. Dimopoulos, Halyna Pylypenko, Holger W. Auner, Xavier Leleu, Ganna Usenko, Roman Hájek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don Ambrose Stevens, Hang Quach, Sundar Jagannath, Phillipe Moreau, Moshe Levy, Ashraf Badros, Larry D. Anderson, Nizar J. Bahlis, Thierry Facon, Maria Victoria Mateos, Michele Cavo, Hua Chang, Yosef Landesman, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Sebastian Grosicki, Paul G. Richardson ... other authors | |
| Year: 2021, AMERICAN JOURNAL OF HEMATOLOGY | |
| journal article | |
| Selinexor, selective inhibitor of nuclear export: Unselective bullet for blood cancers | |
| Kateřina Benková, Jana Fečková Mihályová, Roman Hájek, Tomáš Jelínek | |
| Year: 2021, Blood Reviews | |
| journal article | |
| Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network | |
| Davine Hofste op Bruinink, Stefania Oliva, Lucie Rihova, Alexander Schmitz, Milena Gilestro, Jeroen te Marvelde, Romana Kralova, Helle Hoholt, Annemiek Broijl, Hans Erik Johnsen, Roman Hájek, Mario Boccadoro, Pieter Sonneveld, Paola Omede, Vincent H. J. van der Velden ... other authors | |
| Year: 2021, Haematologica | |
| journal article | |
| Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network | |
| Davine Hofste Op Bruinink, Stefania Oliva, Lucie Rihova, Alexander Schmitz, Milena Gilestro, Jeroen te Marvelde, Romana Kralova, Helle Hoholt, Annemiek Broijl, Hans Erik Johnsen, Roman Hájek, Mario Boccadoro, Pieter Sonneveld, Paola Omede, Vincent H. J. van der Velden ... other authors | |
| Year: 2021, Haematologica | |
| journal article | |
| Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice | |
| Jiri Minarik, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomáš Jelínek, Ludek Pour, Petr Pavlicek, Martin Mistrik, Lucie Brozova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, Lukas Stejskal, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, Vladimir Maisnar, Roman Hájek ... other authors | |
| Year: 2021, BMC CANCER | |
| journal article | |
| Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies | |
| Katarina Hradska, Roman Hájek, Tomáš Jelínek | |
| Year: 2021, Frontiers in Pharmacology | |
| journal article | |
| Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group | |
| Philippe Moreau, Shaji K. Kumar, Jesus San Miguel, Faith Davies, Elena Zamagni, Nizar Bahlis, Heinz Ludwig, Joseph Mikhael, Evangelos Terpos, Fredrik Schjesvold, Thomas Martin, Kwee Yong, Brian G. M. Durie, Thierry Facon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels van de Donk, Sagar Lonial, Michele Cavo, Sigurdur Y. Kristinsson, Suzanne Lentzsch, Roman Hájek, Kenneth C. Anderson, Cristina Joao, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafael Fonseca, Annette Vangsted, Katja Weisel, Rachid Baz, Vania Hungria, Jesus G. Berdeja, Fernando Leal da Costa, Angelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Blade, Xavier Leleu, Eloisa Riva, Peter Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf-Henrik Mellqvist, Dominik Dytfeld, Jean-Luc Harousseau, Hartmut Goldschmidt, Jacob Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksac, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah Holstein, Orhan Sezer, Simon Harrison, Hareth Nahi, Gordon Cook, Maria-Victoria Mateos, S. Vincent Rajkumar, Meletios A. Dimopoulos, Paul G. Richardson ... other authors | |
| Year: 2021, Lancet Oncology | |
| journal article | |
| Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation | |
| Jakub Radocha, Tomáš Jelínek, Ludek Pour, Ivan Spicka, Jiri Minarik, Tereza Popkova, Alexandra Jungova, Petr Pavlicek, Lucie Brozova, Martin Stork, Frantisek Sedlak, Petra Krhovska, Vladimir Maisnar, Adriana Heindorfer, Michal Sykora, Marek Wrobel, Peter Mikula, Petr Kessler, Jana Ullrychova, Roman Hájek ... other authors | |
| Year: 2021, International Journal of Laboratory Hematology | |
| journal article | |
| Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort | |
| Lucie Huvarova, Zdeněk Kořístek, Tomáš Jelínek, Lucie Cerna, Jana Smejkalova, Milan Navrátil, Lukas Grebenicek, Ivana Tvrda, Magda Michalikova, Roman Hájek ... other authors | |
| Year: 2021, Transfusion | |
| journal article | |
| 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde | |
| Pellegrino Musto, Monika Engelhardt, Jo Caers, Niccolo Bolli, Martin Kaiser, Niels van de Donk, Evangelos Terpos, Annemiek Broijl, Carlos Fernandez de Larrea, Francesca Gay, Hartmut Goldschmidt, Roman Hájek, Annette Juul Vangsted, Elena Zamagni, Sonja Zweegman, Michele Cavo, Meletios Dimopoulos, Hermann Einsele, Heinz Ludwig, Giovanni Barosi, Mario Boccadoro, Maria-Victoria Mateos, Pieter Sonneveld, Jesus San Miguel ... other authors | |
| Year: 2021, Haematologica | |
| journal article | |
| A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers | |
| Benjamin Motais, Sandra Charvátová, Matouš Hrdinka, Michal Šimíček, Tomáš Jelínek, Tereza Ševčíková, Zdeněk Kořístek, Roman Hájek, Julio Rodriguez Bago ... other authors | |
| Year: 2020, CANCERS | |
| journal article | |
| A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide | |
| Gamberi Barbara, Berthou Christian, Hernandez Miguel, Semenzato Gianpietro, Tholouli Eleni, Roman Hájek, Caers Jo, Dimopoulos Meletios, Minnema Monique C., Andreasson Bjorn, Parreira Joana, Crotty Gerard, Remes Kari, Kueenburg Elisabeth, Rosettani Barbara, Di Micco Antonia, Peters Sarah, Bacon Pamela, Blau Igor Wolfgang ... other authors | |
| Year: 2020, Clinical Lymphoma Myeloma & Leukemia | |
| journal article | |
| A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma | |
| Roman Hájek, Luděk Pour, Edyta Dawbovská, Muhit Ozcan, Jesus Martin Sanchez, Ivan Špička ... other authors | |
| Year: 2020, EUROPEAN JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | |
| Cavo Michele, Gay Francesca, Beksac Meral, Pantani Lucia, Petrucci Maria Teresa, Dimopoulos Meletios A., Dozza Luca, van der Holt Bronno, Zweegman Sonja, Oliva Stefania, van der Velden Vincent H. J., Zamagni Elena, Palumbo Giuseppe A., Patriarca Francesca, Montefusco Vittorio, Galli Monica, Maisnar Vladimir, Gamberi Barbara, Hansson Markus, Belotti Angelo, Pour Ludek, Ypma Paula, Grasso Mariella, Croockewit Alexsandra, Ballanti Stelvio, Offidani Massimo, Vincelli Iolanda D., Zambello Renato, Liberati Anna Marina, Andersen Niels Frost, Broijl Annemiek, Troia Rossella, Pascarella Anna, Benevolo Giulia, Levin Mark-David, Bos Gerard, Ludwig Heinz, Aquino Sara, Morelli Anna Maria, Wu Ka Lung, Boersma Rinske, Roman Hájek, Durian Marc, di Toritto Tommaso Caravita, Zander Thilo, Specchia Giorgina, Waage Anders, Gimsing Peter, Mellqvist Ulf-Henrik, Kooy Marinus van Marwijk, Minnema Monique, Mandigers Caroline, Cafro Anna Maria, Palmas Angelo, Carvalho Susanna, Spencer Andrew, Boccadoro Mario, Sonneveld Pieter ... other authors | |
| Year: 2020, LANCET HAEMATOLOGY | |
| journal article | |
| Bispecifické protilátky v léčbě non-hodgkinských lymfomů | |
| Jana Fečková Mihályová, Katarína Hradská, Tomáš Jelínek, Roman Hájek | |
| Year: 2020, Farmakoterapie | |
| journal article | |
| Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis | |
| Kastritis Efstathios, Leleu Xavier, Arnulf Bertrand, Zamagni Elena, Cibeira Maria Teresa, Kwok Fiona, Roman Hájek, Moreau Philippe, Jaccard Arnaud, Schoenland Stefan O., Filshie Robin, Nicolas-Virelizier Emmanuelle, Mateos Maria-Victoria, Wechalekar Ashutosh, Hachulla Eric, Milani Paolo, Dimopoulos Meletios A., Fermand Jean-Paul, Foli Andrea, Gavriatopoulou Maria, Klersy Catherine, Palumbo Antonio, Sonneveld Pieter, Johnsen Hans Erik, Merlini Giampaolo, Palladini Giovanni ... other authors | |
| Year: 2020, Journal of Clinical Oncology | |
| journal article | |
| Bortezomib Retreatment Is Effective in Relapsed Multiple Myeloma Patients - Real-Life Clinical Practice Data | |
| M. Stork, S. Ševčíková, L. Brožová, I. Špička, V. Maisnar, J. Minařík, A. Jungová, E. Gregora, R. Velichová, Roman Hájek, Tomáš Jelínek, L. Pour ... other authors | |
| Year: 2020, Neoplasma | |
| journal article | |
| Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients | |
| David Vrabel, Lenka Sedlaříková, Lenka Besse, Lucie Říhová, Renata Bezděková, Martina Almasi, Veronika Kubaczková, Lucie Brožová, Jiří Jarkovský, Hana Plonková, Tomáš Jelínek, Viera Sandecká, Martin Stork, Luděk Pour, Sabina Ševčíková, Roman Hájek ... other authors | |
| Year: 2020, European Journal of Haematology | |
| journal article | |
| Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product | |
| Niederwieser Dietger, Hamm Caroline, Cobb Patrick, Mo Mindy, Forsyth Cecily, Tucci Alessandra, Hanes Vladimir, Delwail Vincent, Roman Hájek, Chien David ... other authors | |
| Year: 2020, Targeted Oncology | |
| journal article | |
| First-line therapy with either bortezomibmelphalan- prednisone or lenalidomidedexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials | |
| A. Larocca, R. Mina, M. Offidani, Roman Hájek | |
| Year: 2020, Haematologica | |
| journal article | |
| Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2020 | |
| Demel Ivo, Julio Rodriguez Bago, Roman Hájek, Tomáš Jelínek | |
| Year: 2020, British Journal of Haematology | |
| journal article | |
| Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model | |
| Roman Hájek, Sandecka Viera, Spicka Ivan, Raab Marc, Goldschmidt Hartmut, Beck Susanne, Minarik Jiri, Pavlicek Petr, Radocha Jakub, Heindorfer Adriana, Tomáš Jelínek, Stejskal Lukas, Brozova Lucie, Sevcikova Sabina, Straub Jan, Pika Tomas, Pour Ludek, Maisnar Vladimir, Seckinger Anja, Hose Dirk ... other authors | |
| Year: 2020, British Journal of Haematology | |
| journal article | |
| Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphoma | |
| Katarina Hradská, Michal Kaščák, Roman Hájek, Tomáš Jelínek | |
| Year: 2020, Expert Review of Hematology | |
| journal article | |
| Intercellular Mitochondrial Transfer in the Tumor Microenvironment | |
| Hana Šahinbegović, Tomáš Jelínek, Matouš Hrdinka, Julio Rodriguez Bago, Marcello Turi, Tereza Ševčíková, Amina Kurtovic-Kotaric, Roman Hájek, Michal Šimíček ... other authors | |
| Year: 2020, Cancers | |
| journal article | |
| International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM) | |
| Mateos Maria-Victoria, Kumar Shaji, Dimopoulos Meletios A., Gonzalez-Calle Veronica, Kastritis Efstathios, Roman Hájek, Fernandez De Larrea Carlos, Morgan Gareth J., Merlini Giampaolo, Goldschmidt Hartmut, Geraldes Catarina, Gozzetti Alessandro, Kyriakou Charalampia, Garderet Laurent, Hansson Markus, Zamagni Elena, Fantl Dorotea, Leleu Xavier, Kim Byung-Su, Esteves Graca, Weiss Brendan M., Rajkumar S. Vincent, Durie Brian G. M., San-Miguel Jesus ... other authors | |
| Year: 2020, Blood Cancer Journal | |
| journal article | |
| Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial | |
| Dimopoulos Meletios A., Špička Ivan, Quach Hang, Oriol Albert, Roman Hájek, Garg Mamta, Beksac Meral, Bringhen Sara, Katodritou Eirini, Chng Wee-Joo, Leleu Xavier, Iida Shinsuke, Mateos María-Victoria, Morgan Gareth, Vorog Alexander, Labotka Richard, Wang Bingxia, Palumbo Antonio, Lonial Sagar, TOURMALINE-MM4 study group undefined ... other authors | |
| Year: 2020, Journal of Clinical Oncology | |
| journal article | |
| Léčba nemocné s nízce rizikovou primární myelofibrózou ruxolitinibem | |
| Jana Zuchnická, Lukáš Stejskal, Roman Hájek | |
| Year: 2020, We Make Media, s.r.o. | |
| specialist book chapter | |
| Léčba relapsu akutní promyelocytární leukemie oxidem arsenitým u chronicky dialyzované pacientky | |
| Kateřina Benková, Zdeněk Kořístek, Petra Richterová, Jana Fečková Mihályová, Dagmar Zámoravcová, Karel Lach, Roman Hájek ... other authors | |
| Year: 2020, Onkologická revue | |
| journal article | |
| Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial | |
| Bringhen Sara, D Agostino Mattia, Paris Laura, Ballanti Stelvio, Pescosta Norbert, Spada Stefano, Pezzatti Sara, Grasso Mariella, Rota-Scalabrini Delia, De Rosa Luca, Pavone Vincenzo, Gazzera Giulia, Aquino Sara, Poggiu Marco, Santoro Armando, Gentile Massimo, Baldini Luca, Petrucci Maria Teresa, Tosi Patrizia, Marasca Roberto, Cellini Claudia, Palumbo Antonio, Falco Patrizia, Roman Hájek, Boccadoro Mario, Larocca Alessandra ... other authors | |
| Year: 2020, Haematologica | |
| journal article | |
| Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) | |
| Terpos Evangelos, Engelhardt Monika, Cook Gordon, Gay Francesca, Mateos Maria-Victoria, Ntanasis-Stathopoulos Ioannis, van de Donk Niels W. C. J., Avet-Loiseau Herve, Roman Hájek, Vangsted Annette Juul, Ludwig Heinz, Zweegman Sonja, Moreau Philippe, Einsele Hermann, Boccadoro Mario, San Miguel Jesus, Dimopoulos Meletios A., Sonneveld Pieter ... other authors | |
| Year: 2020, LEUKEMIA | |
| journal article | |
| Melflufen for relapsed and refractory multiple myeloma | |
| Oriol Albert, Larocca Alessandra, Leleu Xavier, Roman Hájek, Hassoun Hani, Rodriguez-Otero Paula, Paner Agne, Schjesvold Fredrik H., Gullbo Joachim, Richardson Paul G. ... other authors | |
| Year: 2020, Expert Opinion on Investigational Drugs | |
| journal article | |
| Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data | |
| M. Campioni, I. Agirrezabel, Roman Hájek, J. Minařík, L. Pour, I. Špička, S. Gonzalez-McQuire, P. Jandová, V. Maisnar ... other authors | |
| Year: 2020, European Journal of Health Economics | |
| journal article | |
| Mnohočetný myelom | |
| Tomáš Jelínek, Roman Hájek | |
| Year: 2020, Maxdorf, s.r.o. | |
| specialist book chapter | |
| Monoclonal antibodies in the treatment of AL amyloidosis: co-targetting the plasma cell clone and amyloid deposits | |
| Tereza Popková, Roman Hájek, Tomáš Jelínek | |
| Year: 2020, BRITISH JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Monočetný myelom | |
| Roman Hájek, Vladimír Maisnar, Jiří Minařík, Lukáš Stejskal, Petr Pavlíček, Tomáš Jelínek, Alexandra Jungová, Petr Kesseler, Luděk Pour, Michal Sýkora, Ivan Špička, Jana Ullrychová, Adriana Heindorfer, Marek Wróbel ... other authors | |
| Year: 2020, Česká hematologická společnost ČLS JEP | |
| specialist book chapter | |
| Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 ARROW study subgroup analysis | |
| Dimopoulos Meletios A., Niesvizky Ruben, Weisel Katja, Siegel David S., Roman Hájek, Mateos Maria-Victoria, Huang Mei, Zahlten-Kumeli Anita, Moreau Philippe ... other authors | |
| Year: 2020, Blood Cancer Journal | |
| journal article | |
| Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial | |
| Grosicki Sebastian, Simonova Maryana, Spicka Ivan, Pour Ludek, Kriachok Iryrna, Gavriatopoulou Maria, Pylypenko Halyna, Auner Holger W., Leleu Xavier, Doronin Vadim, Usenko Ganna, Bahlis Nizar J., Roman Hájek, Benjamin Reuben, Dolai Tuphan K., Sinha Dinesh K., Venner Christopher P., Garg Mamta, Gironella Mercedes, Jurczyszyn Artur, Robak Pawel, Galli Monica, Wallington-Beddoe Craig, Radinoff Atanas, Salogub Galina, Stevens Don A., Basu Supratik, Liberati Anna M., Quach Hang, Goranova-Marinova Vesselina S., Bila Jelena, Katodritou Eirini, Oliynyk Hanna, Korenkova Sybiryna, Kumar Jeevan, Jagannath Sundar, Moreau Phillipe, Levy Moshe, White Darrell, Gatt Moshe E., Facon Thierry, Cavo Michele, Reece Donna, Anderson Larry D., Saint-Martin Jean-Richard, Jeha Jacqueline, Joshi Anita A., Chai Yi, Li Lingling, Peddagali Vishnuvardhan, Arazy Melina, Shah Jatin, Shacham Sharon, Kauffman Michael G., Dimopoulos Meletios A., Richardson Paul G., Delimpasi Sosana ... other authors | |
| Year: 2020, Lancet | |
| journal article | |
| Osteolytická ložiska, hyperkalcemie a paraprotein, ale myelom to není | |
| Katarína Hradská, Tomáš Jelínek, Juraj Ďuraš, Jana Fečková Mihályová, Tereza Popková, Jakub Cvek, Bukovanský K., Martin Havel, Veronika Spáčilová, Roman Hájek ... other authors | |
| Year: 2020, Vnitrni Lekarstvi | |
| journal article | |
| Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs | |
| M. Vittorio, G. Francesca, S. Spada, Roman Hájek | |
| Year: 2020, HAEMATOLOGICA | |
| journal article | |
| Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma | |
| E. Terpos, K. Ramasamy, N. Maouche, J. Minařík, I. Ntanasis-Stathopoulos, E. Katodritou, W. M. Jenner, H. Plonková, M. Kotsoupolou, J. Kothari, Tomáš Jelínek, A. M. Dimopoulos, A. Zomas, Roman Hájek ... other authors | |
| Year: 2020, ANNALS OF HEMATOLOGY | |
| journal article | |
| Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd | |
| A. Chari, P.G. Richardson, D. Romanus, Roman Hájek | |
| Year: 2020, Expert Review of Hematology | |
| journal article | |
| Současná doporučení pro léčbu mnohočetného myelomu | |
| Hana Plonková, Tomáš Jelínek, Tereza Popková, Roman Hájek | |
| Year: 2020, Acta medicinae | |
| journal article | |
| Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination | |
| Garces Juan-Jose, Michal Šimíček, Vicari Marco, Brozova Lucie, Burgos Leire, Bezdekova Renata, Alignani Diego, Calasanz Maria-Jose, Kateřina Growková, Goicoechea Ibai, Agirre Xabier, Pour Ludek, Prosper Felipe, Rios Rafael, Martinez-Lopez Joaquin, Millacoy Pamela, Palomera Luis, Del Orbe Rafael, Perez-Montana Albert, Garate Sonia, Blanco Laura, Lasa Marta, Maiso Patricia, Flores-Montero Juan, Sanoja-Flores Luzalba, Chyra Zuzana, Alexander Vdovin, Sevcikova Tereza, Tomáš Jelínek, Botta Cirino, El Omri Halima, Keats Jonathan, Orfao Alberto, Roman Hájek, San-Miguel Jesus F., Paiva Bruno ... other authors | |
| Year: 2020, LEUKEMIA | |
| journal article | |
| Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort | |
| Tomáš Jelínek, Popkova Tereza, Juraj Ďuraš, Jana Fečková Mihályová, Michal Kaščák, Kateřina Benková, Plonkova Hana, Lucie Černá, Zdeněk Kořístek, Michal Šimíček, Roman Hájek ... other authors | |
| Year: 2020, HEMATOLOGICAL ONCOLOGY | |
| journal article | |
| Získaná hemofilie A: možnosti diagnostiky a léčby | |
| Jaromír Gumulec, Zdeněk Kořístek, Milan Navrátil, David Buffa, Katarína Hradská, Lucie Recová, Radomíra Hrdličková, Martin Pulcer, Zuzana Čermáková, Roman Hájek ... other authors | |
| Year: 2020, Acta Medicinae | |
| journal article | |
| Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial | |
| Roman Hájek | |
| Year: 2019, LANCET | |
| journal article | |
| Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma | |
| T. Tacon, JH Lee, P. Morau, R. Niesvizky, M. Dimopoulos, Roman Hájek, L. Pour, A. Jurczyszyn, L. Qiu, Z. Klippel, A. Zahlten-Kumeli, M. Osman, B. Paiva, J. San-Miguel ... other authors | |
| Year: 2019, BLOOD | |
| journal article | |
| Comprehensive care improves the prognosis of women with severe HELLP syndrome and postpartal thrombotic microangiopathic syndrome | |
| Jaromír Gumulec, Ondřej Šimetka, Erika Doležálková, Zdeněk Kořístek, Milan Navrátil, Lucie Broskevičová, Lucie Recová, Kateřina Andelová, I. Lochman, J. Martínek, Roman Hájek, David Kaspřák, M. Tvrdá, Kateřina Notari, Lucie Gregorová, Petra Kovářová ... other authors | |
| Year: 2019 | |
| abstract in proceedings | |
| Cytarabine plus G-CSF is more effective than cyclophosphamide plus G-CSF as a stem cell mobilization regimen in multiple myeloma | |
| Roman Hájek, Tomáš Jelínek, Lucie Adamusová, Tereza Popková, Jana Smejkalová, Michal Šimíček, Dana Salounová, Michal Kaščák, Jana Mihalyová, Hana Plonková, Juraj Ďuraš, Milan Navrátil, Zdeněk Kořístek ... other authors | |
| Year: 2019, BONE MARROW TRANSPL | |
| journal article | |
| Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making | |
| Sebastian Gonzalez-McQuire, MA. Dimopoulos, Katja Weisel, Roman Hájek, M. Campioni, C. Bennison, W. Xu, K. Pantiri, M. Hensen, E. Terpoz, S. Knop ... other authors | |
| Year: 2019, MDM Policy & Practice | |
| journal article | |
| Extramedullary disease in multiple myeloma - controversies and future directions | |
| Roman Hájek, Sabina Ševčíková, Jiří Minařík, Martin Stork, Tomáš Jelínek, Luděk Pour ... other authors | |
| Year: 2019, BLOOD REV | |
| journal article | |
| Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma | |
| Roman Hájek, Kim Cocks, Jaqueline Buchanan, Katja Weisel, Shibao Feng, Martin Keiser, Maria-Victoria Mateos, Meletios A. Dimopoulos, Philippe Morea, Heinz Ludwig ... other authors | |
| Year: 2019, BLOOD CANCER JOURNAL | |
| journal article | |
| Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network | |
| Philippe Moreau, Pieter Sonneveld, Mario Boccadoro, Gordon Cook, Ma Victoria Mateos, Hareth Nahi, Hartmut Goldschmidt, Meletios A. Dimopoulos, Paulo Lucio, Joan Blade, Michel Delforge, Roman Hájek, Heinz Ludwig, Thierry Facon, Jesus F. San Miguel, Hermann Einsele ... other authors | |
| Year: 2019, HAEMATOLOGICA | |
| journal article | |
| Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies | |
| Roman Hájek, V. Maisnar, Z. Stefanikova, I. Spicka, L. Pour, J. Minařík, M. Flochová, J. Radocha, E. Gregora, N. Stecová, Tomáš Jelínek, A. Jungová, E. Kralíková, L. Brožová ... other authors | |
| Year: 2019, NEOPLASMA | |
| journal article | |
| Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis | |
| F. Bonello, S. Pulini, S. Ballanti, M. Gentile, S. Spada, O. Annibali, P. Omede, S. Ronconi, C. Cangialosi, L. Podda, Roman Hájek ... other authors | |
| Year: 2019, CANCERS | |
| journal article | |
| Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target? | |
| N. Steiner, D. Nachbaur, B. Borjan, S. Ševčíková, G. Goebel, E. Gunsilius, Roman Hájek ... other authors | |
| Year: 2019, DISEASE MARKERS | |
| journal article | |
| Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases | |
| Roman Hájek, A. Jurczyszyn, J. Davila, K.M. Kortüm, D.S. Jayabalan, R. Vij, M. Fiala, V. Milunovic, C.S. Chim, K. Wiśniewska-Piaty, A. Waszczuk-Gajda, E. Crusoe, P. Robak, M. Raźny, D. Zawirska, M. Bittrich, H. Nahi, H. Liu, J.J. Castillo, D.H. Vesole ... other authors | |
| Year: 2019, Leukemia and Lymphoma | |
| journal article | |
| PREDICTIVE VALUE OF PRIMA?PROGNOSTIC INDEX (PRIMA?PI) IN FIRST RELAPSE OF FOLLICULAR LYMPHOMA | |
| Juraj Ďuraš, V. Procházka, D. Belada, A. Janíková, H. Móciková, Roman Hájek, M. Trněný ... other authors | |
| Year: 2019 | |
| abstract in proceedings | |
| Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients | |
| Roman Hájek, A. Jurczyszyn, J.J. Castillo, I. Avivi, J. Czepiel, J. Davila, R. Vij, M.A. Fiala, A. Gozzetti, N. Grzaśko, V. Milunovic, I. Hus, K. Madry, A. Waszcuk-Gajda, L. Usnarska-Zubkiewicz, J. Debski, E. Atilla, M. Beksac, G. Mele, W. Sawicki, D. Jaybalan, G. Charliński, A.G. Szabo, M. Delforge, A. Kopacz, D. Fantl, A. Waage, E. Crusoe, V. Hungria, P. Richardson, J. Laubach, T. Guerrero-Garcia, J. Liu, D.H. Vesole ... other authors | |
| Year: 2019, Leukemia & Lymphoma | |
| journal article | |
| Simplified novel prognostic score for real-life older adults with multiple myelomaregistry-based analysis | |
| Roman Hájek, J. Radocha, L. Brožová, L. Pour, I. Spicka, J. Minařík, E. Gregorová, A. Jungová, Tomáš Jelínek, A. Heindorfer, M. Sykora, V. Maisnar ... other authors | |
| Year: 2019, ANN HEMATOL | |
| journal article | |
| Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected 'real-world' population | |
| Roman Hájek, Jiří Minařík, Luděk Pour, Vladimír Maisnar, Ivan Špička, Alexandra Jungová, Tomáš Jelínek, Lucie Brožová, Petra Krhovská, Vlastimil Scudla ... other authors | |
| Year: 2019, BIOMEDICAL PAPERS-OLOMOUC | |
| journal article | |
| Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14) | |
| Roman Hájek, Tomáš Jelínek, Jana Fečková Mihályová, Juraj Ďuraš, Tereza Popková, Kateřina Benková, Hana Plonková, Jana Zuchnická, Lucie Broskevičová, Lucie Huvarová, Lucie Černá, Kateřina Growková, Michal Šimíček, Martin Havel, Jaromír Gumulec, Zdeněk Kořístek, Bruno Paiva, Petra Richterová, Milan Navrátil, Michal Kascák ... other authors | |
| Year: 2019, AMERICAN JOURNAL OF HEMATOLOGY | |
| journal article | |
| Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia | |
| Zdeněk Král, Jozef Michalka, Heidi Mociková, Jana Marková, Alice Sýkorová, David Belada, Alexandra Jungová, Samuel Vokurka, Marie Lukášová, Vít Procházka, Juraj Ďuraš, Roman Hájek, Ladislav Dušek, Luhos Drgona, Miriam Ladická, Veronika Ballová, Andrei Vranovský ... other authors | |
| Year: 2019, JOURNAL OF CANCER | |
| journal article | |
| A phase I/II dose-escalation study investigating all-oral ixazomib-melphalanprednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma | |
| Jesús F. San-Miguel, Maria-Asunción Echeveste Gutierrez, Ivan Špicka, María-Victoria Mateos, Kevin Song, Michael D. Craig, Joan Bladé, Roman Hájek, Christine Chen, Alessandra Di Bacco, Jose Estevam, Neeraj Gupta, Catriona Byrne, Vickie Lu, Helgi van de Velde, Sagar Lonial ... other authors | |
| Year: 2018, HAEMATOL-HEMATOL J | |
| journal article | |
| Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients | |
| Tomáš Jelínek, Roman Hájek, V. Maisnar, L. Pour, I. Špička, J. Minařík, E. Gregora, P. Kessler, M. Sýkora, H. Fraňková, D. Adamová, M. Wróbel, P. Mikula, J. Jarkovský, J. Diels, X. Gatopoulou, H Besson, L. Brožová, T. lto, Š. Veselá ... other authors | |
| Year: 2018, Current Medical Research and Opinion | |
| journal article | |
| Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials | |
| Roman Hájek, AK Stewart, SD Russell, P. Moreau, J. Herrmann, J. Banchs, J. Groarke, AR Lyon, GN Batty, S. Ro, M. Huang, KS Iskander, D. Lenihan, A. Chari ... other authors | |
| Year: 2018, Blood Advances | |
| journal article | |
| Automatizované promývání transplantátů krvetvorných buněk pro autologní použití | |
| Lucie Adamusová, Zdeněk Kořístek, Jana Smejkalová, Milan Navrátil, Lukáš Grebeníček, Ivana Tvrdá, Magda Michalíková, Roman Hájek ... other authors | |
| Year: 2018, Transfuze a hematologie dnes | |
| journal article | |
| CD38 cílená léčba u mnohočetného myelomu | |
| Tomáš Jelínek, Jana Fečková Mihályová, Roman Hájek | |
| Year: 2018, Vnitřní lékařství | |
| journal article | |
| Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project | |
| A. Hoering, M. Cavo, SZ Usmani, J. San Miguel, H. Goldschimdt, I. Turesson, JJ Lahuerta, M. Attal, B. Barlogie, JH Lee, S. Kumar, S. Lenhoff, G. Morgan, SV Rajkumar, BGM Durie, P. Moreau, Roman Hájek ... other authors | |
| Year: 2018, Blood Cancer Journal | |
| journal article | |
| European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias | |
| Roman Hájek, M. Gavriatopoulou, P. Musto, J. Caers, G. Merlini, E. Kastritis, N. van de Donk, F. Gay, U. Hegenbart, S. Zweegman, B. Bruno, C. Straka, MA. Dimopoulos, H. Einsele, M. Boccadoro, P. Sonneveld, M. Engelhardt, E. Terpos ... other authors | |
| Year: 2018, Leukemia | |
| journal article | |
| From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives | |
| F. Gay, M. Engelhardt, E. Terpos, R. Wasch, L. Giaccone, H.W. Auner, J. Caers, M. Gramatzki, N. van de Donk, S. Oliva, E. Zamagni, L. Garderet, Ch. Straka, Roman Hájek, H. Ludwig, H. Einsele, M. Dimopoulos, M. Boccadoro, N. Kroger, M. Cavo, H. Goldschmidt, B. Bruno, P. Sonneveld ... other authors | |
| Year: 2018, HAEMATOLOGICA | |
| journal article | |
| Maintenance Treatment and Survival in Patients With Myeloma A Systematic Review and Network Meta-analysis | |
| F. Gay, G. Jackson, L. Rosinol, S.A. Holstein, P. Moreau, S. Spada, F. Davies, J.J. Lahuerta, X. Leleu, S. Bringhen, A. Evangelista, C. Hulin, U. Panzani, D.A. Cairns, F. Di Raimondo, M. Macro, A.M. Liberati, C. Pawlyn, M. Offidani, A. Spencer, Roman Hájek, E. Terpos, G.J. Morgan, J. Blade, P. Sonneveld, J. San-Miguel, P.L. McCarthy, H. Ludwig, M. Boccadoro, MV Mateos, M. Attal ... other authors | |
| Year: 2018, Jama Oncology | |
| journal article | |
| Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing | |
| Zuzana Kufová, Tereza Ševčíková, J. Januska, P. Vojta, A. Boday, P. Vanickova, Jana Filipová, Kateřina Growková, Tomáš Jelínek, M. Hajduch, Roman Hájek ... other authors | |
| Year: 2018, JOURNAL OF CLINICAL PATHOLOGY | |
| journal article | |
| Obinutuzumab v první linii léčby chronické lymfocytární leukemie - zkušenosti z klinické praxe | |
| J. Zuchnicka, J. Feckova Mihalyova, L. Istvanikova, Roman Hájek | |
| Year: 2018, Remedia, Od teorie k praxi | |
| journal article | |
| Plasma levels of the angiogenic cytokine Endocan are elevated in patients with multiple myeloma | |
| Roman Hájek | |
| Year: 2018 | |
| abstract in proceedings | |
| Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network | |
| Roman Hájek, H. Ludwig, M. Delforge, T. Facon, H. Einsele, F. Gay, P. Moreau, H. Avet-Loiseau, M. Boccadoro, M. Mohty, M. Cavo, MA Dimopoulos, JF San-Miguel, E. Terpos, S. Zweegman, L. Garderet, MV Mateos, G. Cook, X. Leleu, H. Goldschmidt, G. Jackson, M. Kaiser, K. Weisel, NWCJ van de Donk, A. Waage, M. Beksac, UH Mellqvist, M. Engelhardt, J. Caers, C. Driessen, J. Blade, P. Sonneveld ... other authors | |
| Year: 2018, LEUKEMIA | |
| journal article | |
| Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients | |
| A. Jurczyszyn, J. Radocha, J. Davila, M.A. Fiala, A. Gozzetti, N. Grzasko, P. Robak, I. Hus, A. Waszczuk-Gajda, R. Guzicka-Kazimierczak, E. Atilla, G. Mele, W. Sawicki, D.S. Jayabalan, G. Charlinski, A.G. Szabo, Roman Hájek ... other authors | |
| Year: 2018, BRITISH JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies | |
| Roman Hájek, J. Jarkovsky, V. Maisnar, L. Pour, I. Spicka, J. Minarik, E. Gregora, P. Kessler, M. Sykora, H. Frankova, M. Campion, L. DeCosta, M. Treur, S. Gonzales-McQuire, W. Bouwmeester ... other authors | |
| Year: 2018, Clinical Lymphoma Myeloma & Leukemia | |
| journal article | |
| The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets | |
| Roman Hájek, Normann Steiner, Udo Müller, Sabina Sevcikova, Bojana Borjan, Karin Jöhrer, Georg Göbel, Andreas Pircher, Eberhard Gunsilius ... other authors | |
| Year: 2018, PUBLIC LIBRARY SCIENCE | |
| journal article | |
| The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple Myeloma | |
| Roman Hájek, N. Steiner, S. Sevcikova, B. Borjan, G. Untergasser, G. Göbel, E. Gunsilius ... other authors | |
| Year: 2018, Anticancer Research | |
| journal article | |
| The start of a new wave: Developments in proteasome inhibition in multiple myeloma | |
| Roman Hájek, K. Yong, S. Gonzalez-McQuire, Z. Szabo, P. Schoen | |
| Year: 2018, EUROPEAN JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Treatment and outcome patterns in European patients with Waldenstrom's macroglobulinaemia: a large, observational, retrospective chart review | |
| Roman Hájek, C. Buske, S. Sadullah, E. Kastritis, A. Tedeschi, R. García-Sanz, L. Bolkun, X. Leleu, W. Willenbacher, MC. Minnema, M. Cheng, E. Bilotti, T. Graef, MA. Dimopoulos ... other authors | |
| Year: 2018, The Lancet Haematology | |
| journal article | |
| Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response | |
| Roman Hájek, R. Mina, MT Petrucci, S. Spada, F. Patriarca, C. Cerrato, L. De Paoli, N. Pescosta, R. Ria, A. Malfitano, P. Musto, L. Baldini, T. Guglielmelli, B. Gamberi, D. Mannina, G. Benevolo, R. Zambello, AP Falcone, A. Palumbo, A. Nagler, V. Calafiore, A. Spencer, M. Boccadoro, P. Corradini, S. Bringhen ... other authors | |
| Year: 2018, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | |
| journal article | |
| Treatment Outcomes of Real Life Elderly Multiple Myeloma Patients: A Analysis from Registry of Monoclonal Gammopathies (RMG) | |
| Roman Hájek | |
| Year: 2018 | |
| abstract in proceedings | |
| Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma | |
| Tomáš Jelínek, Roman Hájek, B. Paiva | |
| Year: 2018, Frontiers in Immunology | |
| journal article | |
| Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies | |
| Jakub Radocha, Vladimír Maisnar, Luděk Pour, Ivan Špička, Jiři Minařík, Petr Pavlíček, Alexandra Jungová, Marta Krejčí, Tomáš Pika, Jan Straub, Lucie Brožová, Lukáš Stejskal, Adriana Heindorfer, Pavel Jindra, Petr Kessler, Peter Mikula, Michal Sýkora, Marek Wróbel, Jiří Jarkovský, Roman Hájek, Lenka Szeligová ... other authors | |
| Year: 2018, Cancer Medicine | |
| journal article | |
| Venetoclax: A new wave in hematooncology | |
| Jana Fečková Mihályová, Tomáš Jelínek, K. Growková, Matouš Hrdinka, Michal Šimíček, Roman Hájek ... other authors | |
| Year: 2018, EXPERIMENTAL HEMATOLOGY | |
| journal article | |
| A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS) | |
| Roman Hájek, T. Masszi, M. T. Petrucci, A. Palumbo, L. Rosinol, A. Nagler, K. L. Yong, A. Oriol, J. Minarik, M.A. Dimopoulos, V. Maisnar, D. Rossi, H. Kasparu, J. Van Droogenbroeck, D. B. Yehuda, I. Hardan, M. Jenner, M. Calbecka, M. Dávid, J. de la Rubia, J. Drach, Z. Gasztonyi, S. Górnik, X. Leleu, M. Munder, M. Offidani, N. Zojer, K. Rajangam, Y-L Chang, J. F. San-Miguel, H. Ludwig, L. Pour ... other authors | |
| Year: 2017, LEUKEMIA | |
| journal article | |
| Activity of aldehyde dehydrogenase in B-cell and plasma cell subsets of monoclonal gammopathy patients and healthy donors | |
| P. Všianská, R. Bezděková, Fedor Kryukov, M. Almáši, L. Pour, M. Penka, Roman Hájek, L. Říhová ... other authors | |
| Year: 2017, EUROPEAN JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Asymptomatic and treatment-requiring multiple myeloma - Data from the czech registry of monoclonal gammopathies | |
| L. Brozova, J. Jarkovsky, L. Pour, J. Minarik, A. Jungova, E. Gregora, I. Spicka, V. Maisnar, Roman Hájek ... other authors | |
| Year: 2017, Klinicka Onkologie | |
| journal article | |
| Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis | |
| F. Gay, S. Oliva, M.T. Petrucci, V. Montefusco, C. Conticello, P. Musto, L. Catalano, A. Evangelista, S. Spada, P. Campbell, R. Ria, M. Salvini, M. Offidani, A.M. Carella, P. Omede, A.M. Liberati, R. Troia, A.M. Cafro, A. Malfitano, A.P. Falcone, T. Caravita, F. Patriarca, A. Nagler, A. Spencer, Roman Hájek, A. Palumbo, M. Boccadoro ... other authors | |
| Year: 2017, LEUKEMIA | |
| journal article | |
| Bezdůvodný rozruch, nebo neuvěřitelný progres? | |
| Roman Hájek | |
| Year: 2017, Remedia | |
| journal article | |
| Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies | |
| Tereza Ševčíková, Kateřina Growková, Zuzana Kufová, Jana Filipová, P. Vrublová, Tomáš Jelínek, Zdeněk Kořístek, Fedor Kryukov, Elena Kryukova, Roman Hájek ... other authors | |
| Year: 2017, JOURNAL OF CLINICAL PATHOLOGY | |
| journal article | |
| Biomarkers in immunoglobulin light chain amyloidosis | |
| Zuzana Kufová, Tereza Ševčíková, Kateřina Growková, P. Vojta, Jana Filipová, Z. Adam, L. Pour, M. Penka, R. Rysava, P. Nemec, L. Brozova, P. Vychytilova, A. Jurczyszyn, S. Grosicki, A. Barchnicka, M. Hajduch, Roman Hájek, Michal Šimíček ... other authors | |
| Year: 2017, Klinicka Onkologie | |
| journal article | |
| Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup | |
| H. Ludwig, M. A. Dimopoulos, P. Moreau, W-J Chng, H. Goldschmidt, Roman Hájek, T. Facon, L. Pour, R. Niesvizky, A. Oriol, L. Rosinol, A. Suvorov, G. Gaidano, T. Pika, K. Weisel, V. Goranova-Marinova, A. Palumbo, H. H. Gillenwater, N. Mohamed, S. Aggarwal, S. Feng, D. Joshua ... other authors | |
| Year: 2017, LEUKEMIA & LYMPHOMA | |
| journal article | |
| Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study | |
| A. Meletios, A. K. Stewart, T. Masszi, I. Špička, A. Oriol, Roman Hájek, L. Rosinol, D. Siegel, G. G. Mihaylov, V. Goranova-Marinova, P. Rajnics, A. Suvorov, R. Niesvizky, A. Jakubowiak, J. San-Miguel, H. Ludwig, A. Palumbo, M. Obreja, S. Aggarwal, P. Moreau ... other authors | |
| Year: 2017, BRITISH JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial | |
| M. A. Dimopoulos, H. Goldschmidt, R. Niesvizky, D. Joshua, W-J Chng, A. Oriol, R. Z. Orlowski, H. Ludwig, T. Facon, Roman Hájek, K. Weisel, V. Hungria, L. Minuk, S. Feng, A. Zahlten-Kumeli, A. S. Kimball, P. Moreau ... other authors | |
| Year: 2017, LANCET ONCOLOGY | |
| journal article | |
| Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR | |
| W-J Chng, H. Goldschmidt, M. A. Dimopoulos, P. Moreau, D. Joshua, A. Palumbo, T. Facon, H. Ludwig, L. Pour, R. Niesvizky, A. Oriol, L. Rosinol, A. Suvorov, G. Gaidano, T. Pika, K. Weisel, V. Goranova-Marinova, H. H. Gillenwater, N. Mohamed, S. Feng, S. Aggarwal, Roman Hájek ... other authors | |
| Year: 2017, LEUKEMIA | |
| journal article | |
| Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment | |
| M. A. Dimopoulos , A. K. Stewart, T. Masszi, I. Špička, A. Oriol, Roman Hájek, L. Rosinol, D. Siegel, G. G. Mihaylov, V. Goranova-Marinova, P. Rajnics, A. Suvorov, R. Niesvizky, A. Jakubowiak, J. San-Miguel, H. Ludwig, S. Ro, S. Aggarwal, P. Moreau, A. Palumbo ... other authors | |
| Year: 2017, BLOOD CANCER JOURNAL | |
| journal article | |
| CRISPR in research and treatment of multiple myeloma | |
| Michal Šimíček, Kateřina Growková, Roman Hájek | |
| Year: 2017, Klinicka Onkologie | |
| journal article | |
| Current applications of multiparameter flow cytometry in plasma cell disorders | |
| Tomáš Jelínek, R. Bezdekova, R. Zatopkova, L. Burgos, Michal Šimíček, Tereza Ševčíková, B. Paiva, Roman Hájek ... other authors | |
| Year: 2017, BLOOD CANCER JOURNAL | |
| journal article | |
| Czech registry of monoclonal gammopathies - Technical solution, data collection and visualisation | |
| L. Brozova, D. Schwarz, I. Snabl, J. Kalina, B. Pavlickova, M. Komenda, J. Jarkovsky, P. Nemec, D. Horinek, Z. Stefanikova, L. Pour, Roman Hájek, V. Maisnar ... other authors | |
| Year: 2017, Klinicka Onkologie | |
| journal article | |
| Daratumumab - Naděje pro myelomové pacienty, výzva pro klinické laboratoře | |
| Tomáš Jelínek, Martin Kořístka, Zuzana Čermáková, Roman Hájek | |
| Year: 2017, Klinicka Onkologie | |
| journal article | |
| Diagnostic Tools of Waldenström's Macroglobulinemia - Best Possibilities for Non-invasive and Long-term Disease Monitoring | |
| Kateřina Growková, Zuzana Kufová, Tereza Ševčíková, Jana Filipová, M. Kascak, Tomáš Jelínek, S. Grosicki, A. Barchnicka, L. Roziakova, M. Mistrik, M. Simicek, Roman Hájek ... other authors | |
| Year: 2017, Klinická onkologie | |
| journal article | |
| DIFFERENCES IN PATIENT AND DISEASE CHARACTERISTICS OBSERVED AT INITIATION OF FIRST-LINE AND INITIATION OF SECOND-LINE TREATMENT IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA IN THE CZECH REPUBLIC | |
| Roman Hájek | |
| Year: 2017 | |
| abstract in proceedings | |
| Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study | |
| O. Sezer, M. Beksac, Roman Hájek, G. Sucak, S. Cagirgan, W. Linkesch, O. M. Akay, Z. Gülbas, H. Nahi, T. Plesner, J. A. Snowden, A. Timuragaoglu, T. Dechow, A. Lang, T. Tuglular, J. Drach, G. Armbrecht, A. Potamianou, C. Couturier, R. A. Olie, C. Feys, N. Allietta, E. Terpos ... other authors | |
| Year: 2017, BRITISH JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes | |
| P. Hari, M.-V. Mateos, R. Abonour, S. Knop, W. Bensinger, H. Ludwig, K. Song, Roman Hájek, P. Moreau, D.S. Siegel, S. Feng, M. Obreja, S.K. Aggarwal, K. Iskander, H. Goldschmidt ... other authors | |
| Year: 2017, LEUKEMIA | |
| journal article | |
| Epidemiology of multiple myeloma in the Czech Republic | |
| D. Maluskova, I. Svobodova, M. Kucerova, L. Brozova, J. Muzik, J. Jarkovsky, Roman Hájek, V. Maisnar, L. Dusek ... other authors | |
| Year: 2017, Klinicka Onkologie | |
| journal article | |
| Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma | |
| N. Steiner, B. Borjan, Roman Hájek, K. Jöhrer, G. Göbel, W. Willenbacher, J. Kern, E. Gunsilius, G. Untergasser ... other authors | |
| Year: 2017, Oncotarget | |
| journal article | |
| High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma | |
| N. Steiner, Roman Hájek, S. Sevcikova, B. Borjan, K. Jöhrer, G. Göbel, G. Untergasser, E. Gunsilius ... other authors | |
| Year: 2017, PLOS ONE | |
| journal article | |
| Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group | |
| N. Grzasko, Roman Hájek, M. Hus, S. Chocholska, M. Morawska, K. Giannopoulos, K. Czarnocki, A. Druzd-Sitek, B. Pienkowska-Grela, J. Rygier, L. Usnarska-Zubkiewicz, D. Dytfeld, T. Kubicki, A. Jurczyszyn, M. Korpysz, A. Dmoszynska ... other authors | |
| Year: 2017, Leukemia and Lymphoma | |
| journal article | |
| IgM myeloma: A multicenter retrospective study of 134 patients | |
| J. J. Castillo, A. Jurczyszyn, L. Brozova, E. Crusoe, J. Czepiel, J. Davila, A. Dispenzieri, M. Eveillard, M. A. Fiala, I. M. Ghobrial, A. Gozzetti, J. N. Gustine, Roman Hájek, V. Hungria, J. Jarkovsky, D. Jayabalan, J. P. Laubach, B. Lewicka, V. Maisnar, E. E. Manasanch, P. Moreau, E. A. Morgan, H. Nahi, R. Niesvizky, C. Paba-Prada, T. Pika, L. Pour, J. L. Reagan, P. G. Richardson, J. Shah, I. Spicka, R. Vij, A. Waszczuk-Gajda, M. A. Gertz ... other authors | |
| Year: 2017, AMERICAN JOURNAL OF HEMATOLOGY | |
| journal article | |
| Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study | |
| P. Moreau, D. Joshua, W-J Chng, A. Palumbo, H. Goldschmidt, Roman Hájek, T. Facon, H. Ludwig, L. Pour, R. Niesvizky, A. Oriol, L. Rosinol, A. Suvorov, G. Gaidano, T. Pika, K. Weisel, V. Goranova-Marinova, H. H. Gillenwater, N. Mohamed, S. Aggarwal , S. Feng, M. A. Dimopoulos ... other authors | |
| Year: 2017, LEUKEMIA | |
| journal article | |
| INITIAL PHASE 2 RESULTS OF IBRUTINIB COMBINED WITH BORTEZOMIB/DEXAMETHASONE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA | |
| Roman Hájek | |
| Year: 2017 | |
| abstract in proceedings | |
| Lymfomy z B-buněk marginální zóny | |
| Juraj Ďuraš, Michal Kaščák, Roman Hájek | |
| Year: 2017, Onkológia | |
| journal article | |
| MINIMAL RESIDUAL DISEASE BY MULTIPARAMETER FLOW CYTOMETRY IN TRANSPLANT ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA ENROLLED IN THE EMN02/HO95 PHASE 3 TRIAL | |
| Roman Hájek | |
| Year: 2017 | |
| abstract in proceedings | |
| MINIMAL RESIDUAL DISEASE BY MULTIPARAMETER FLOW CYTOMETRY IN TRANSPLANT ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: RESULTS FROM THE EMN02/HO95 PHASE 3 TRIAL | |
| Roman Hájek | |
| Year: 2017 | |
| abstract in proceedings | |
| Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | |
| P. Moreau, J. San Miguel, P. Sonneveld, M. V. Mateos, E. Zamagni, H. Avet-Loiseau, Roman Hájek, M. A. Dimopoulos, H. Ludwig, H. Einsele, S. Zweegman, T. Facon, M. Cavo, E. Terpos, H. Goldschmidt, M. Attal, C. Buske ... other authors | |
| Year: 2017, ANNALS OF ONCOLOGY | |
| journal article | |
| Obinutuzumab v léčbě nemocných s chronickou lymfocytární leukémií a s folikulárním lymfomem | |
| J. Zuchnická, J. F. Mihályová, Juraj Ďuraš, Roman Hájek | |
| Year: 2017, Onkologická revue | |
| journal article | |
| Obtižne interpretovatelné nálezy elektroforéz a imunofixací u pacientu s mnohočetným myelomem po autologní transplantaci | |
| Pavlína Kušnierová, David Zeman, Radka Šigutová, Zdeněk Švagera, Lenka Zahradová, Roman Hájek ... other authors | |
| Year: 2017, Klinicka Biochemie a Metabolismus | |
| journal article | |
| PD-1/PD-L1 inhibitors in haematological malignancies | |
| Tomáš Jelínek, J. Mihalyova, M. Kascak, J. Duras, Roman Hájek | |
| Year: 2017, IMMUNOLOGY | |
| journal article | |
| PD-1/PD-L1 inhibitors in haematological malignancies: update 2017 | |
| Tomáš Jelínek, Roman Hájek, J. Mihalyova, M. Kascak, J. Duras | |
| Year: 2017, Immunology | |
| journal article | |
| PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future | |
| Tomáš Jelínek, Roman Hájek | |
| Year: 2017, ONCOIMMUNOLOGY | |
| journal article | |
| Pixantron v léčbě non-hodgkinských lymfomů | |
| Juraj Ďuraš, Michal Kaščák, Milan Navrátil, Roman Hájek | |
| Year: 2017, Onkologická revue | |
| journal article | |
| Proteasome inhibitors in AL amyloidosis: focus on mechanismof action and clinical activity | |
| Tomáš Jelínek, Elena Kryukova, Zuzana Kufová, Fedor Kryukov, Roman Hájek | |
| Year: 2017, Hematological Oncology | |
| journal article | |
| RISK STRATIFICATION ALGORITHM USING REAL-WORLD DATA FROM PATIENTS WITH RELAPSED AND/ OR REFRACTORY MULTIPLE MYELOMA: DESCRIPTION OF CLINICAL OUTCOME BY TREATMENT REGIMEN | |
| Roman Hájek | |
| Year: 2017 | |
| abstract in proceedings | |
| Současný algoritmus léčby nemocných s mnohočetným myelomem - kam kráčí? | |
| Roman Hájek, Tomáš Jelínek | |
| Year: 2017, Acta medicinae | |
| journal article | |
| THE ORAL PROTEASOME INHIBITOR IXAZOMIB IN COMBINATION WITH MELPHALAN-PREDNISONE FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: PHASE 1/2 DOSE-ESCALATION STUDY (NCT01335685) | |
| Roman Hájek | |
| Year: 2017 | |
| abstract in proceedings | |
| The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma | |
| A. Mikulasova, Ch. P. Wardell, A. Murison, E. M. Boyle, G. H. Jackson, J. Smetana, Zuzana Kufová, L. Pour, V. Sandecka, M. Almasi, P. Vsianska, E. Gregora, P. Kuglik, Roman Hájek, F. E. Davies, G. J. Morgan, B. A. Walker ... other authors | |
| Year: 2017, HAEMATOLOGICA | |
| journal article | |
| Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection | |
| Kateřina Growková, Elena Kryukova, Zuzana Kufová, Jana Filipová, Tereza Ševčíková, L. Rihova, M. Kascak, Fedor Kryukov, Roman Hájek ... other authors | |
| Year: 2017, EUROPEAN JOURNAL OF HAEMATOLOGY | |
| journal article | |
| Whole exome sequencing of aberrant plasma cells in a patient with multiple myeloma minimal residual disease | |
| M. Zatopkova, Jana Filipová, Tomáš Jelínek, Tereza Ševčíková, Michal Šimíček, L. Rihova, R. Bezdekova, Kateřina Growková, Zuzana Kufová, J. Smejkalova, M. Hajduch, L. Pour, J. Minarik, A. Jungova, V. Maisnar, Fedor Kryukov, Roman Hájek ... other authors | |
| Year: 2017, Klinicka Onkologie | |
| journal article | |
| A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis | |
| Roman Hájek | |
| Year: 2016 | |
| abstract in proceedings | |
| A SUBSTUDY OF THE PHASE 3 ENDEAVOR STUDY: SERIAL ECHOCARDIOGRAPHIC ASSESSMENT OF PATIENTS WITH RELAPSED MULTIPLE MYELOMA (RMM) RECEIVING CARFILZOMIB PLUS DEXAMETHASONE OR BORTEZOMIB PLUS DEXAMETHASONE | |
| Roman Hájek | |
| Year: 2016 | |
| abstract in proceedings | |
| AUTOLOGNÍ TRANSPLANTACE KMENOVÝCH BUNĚK U WALDENSTRÖMOVY MAKROGLOBULINEMIE | |
| M. Kasčák, J. Duraš, M. Navrátil, Roman Hájek | |
| Year: 2016, Transfuze a hematologie dnes | |
| journal article | |
| Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study | |
| M.A. Dimopoulos, P. Moreau, A. Palumbo, D. Joshua, L. Pour, Roman Hájek, T. Facon, H. Ludwig, A. Oriol, H. Goldschmidt, L. Rosiňol, J. Straub, A. Suvorov, C. Araujo, E. Rimashevskaya, T. Pika, G. Gaidano, K. Weisel, V. Goranova-Marinova, A. Schwarer, L. Minuk, T. Masszi, I. Karamanesht, M. Offidani, V. Hungria, A. Spencer, R. Z Orlowski, H. H Gillenwater, N. Mohamed, S. Feng, W.J. CHng ... other authors | |
| Year: 2016, LANCET ONCOLOGY | |
| journal article | |
| CARFILZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE: SUBGROUP ANALYSIS OF THE PHASE 3 ENDEAVOR STUDY TO EVALUATE THE IMPACT OF PRIOR TREATMENT ON PATIENTS WITH RELAPSED MULTIPLE MYELOMA | |
| Roman Hájek | |
| Year: 2016 | |
| abstract in proceedings | |
| CARFILZOMIB AND DEXAMETHASONE VS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: ANALYSIS OF THE PHASE 3 ENDEAVOR STUDY BY AGE SUBGROUP | |
| Roman Hájek | |
| Year: 2016 | |
| abstract in proceedings | |
| CARFILZOMIB AND DEXAMETHASONE VS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: RESULTS OF THE PHASE 3 STUDY ENDEAVOR (NCT01568866) | |
| Roman Hájek | |
| Year: 2016 | |
| abstract in proceedings | |
| CARFILZOMIB AND DEXAMETHASONE VS BORTEZOMIB AND DEXAMETHASONE: SUBGROUP ANALYSIS OF PATIENTS WITH RELAPSED MULTIPLE MYELOMA BY BASELINE CYTOGENETIC RISK STATUS (PHASE 3 ENDEAVOR STUDY) | |
| Roman Hájek | |
| Year: 2016 | |
| abstract in proceedings | |
| CARFILZOMIB AND DEXAMETHASONE VS SUBCUTANEOUS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SECONDARY ANALYSIS FROM THE PHASE 3 STUDY ENDEAVOR (NCT01568866) | |
| Roman Hájek | |
| Year: 2016 | |
| abstract in proceedings | |
| Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma | |
| Herve Avet-Loiseau, Rafael Fonseca, David Siegel, Meletios A. Dimopoulus, Ivan Špička, Tomás Masszi, Roman Hájek, Laura Rosiňol, Vesselina Goranova-Marinova, Georgi Mihaylov, Vladimír Maisnar, Maria - Victoria Mateos, Michael Wang, Ruben Niesvizky, Albert Oriol, Andrzej Jakubowiak, Jiří Minarik, Antonio Palumbo, William Bensinger, Vishal Kukreti, Dina Ben-Yehuda, A. Keith Stewart, Mihaela Obreia, Philippe Moreau ... other authors | |
| Year: 2016, Blood | |
| journal article | |
| CCR10/CCL27 crosstalk contributes to failure of proteasomeinhibitors in multiple myeloma | |
| Shanmugapriya Thangavadievel, Claudia Zelle-Riser, Angelika Olivier, Benno Postert, Gerold Untergasser, Johann Kern, Andrea Brunner, Eberhard Gunsilius, Rainer Biedermann, Roman Hájek, Ludek Pour, Wolfgang Willenbacher, Richard Greil, Karin Johrer ... other authors | |
| Year: 2016, ONCOTARGET | |
| journal article | |
| Centrosome amplification and clonal evolution in multiple myeloma: Short review | |
| Elena Kryukova, Fedor Kryukov, Roman Hájek | |
| Year: 2016, CRIT REV ONCOL HEMAT | |
| journal article | |
| Centrosome associated genes pattern for risk sub-stratification in multiple myeloma | |
| Fedor Kryukov, P. Nemec, L. Radova, Elena Kryukova, S. Okubote, J. Minarik, Z. Stefanikova, L. Pour, Roman Hájek ... other authors | |
| Year: 2016, J TRANSL MED | |
| journal article | |
| CIRCULATING SERUM MIRNA PROFILE IN AL AMYLOIDOSIS | |
| Elena Kryukova, Kateřina Growková, Jana Filipová, Fedor Kryukov, Roman Hájek | |
| Year: 2016 | |
| abstract in proceedings | |
| Clonal cytogenetics changes in progression of multiple myeloma to extramedullary relapse and plasmocellular leukemia: a case report | |
| Jan Smetana, Petr Kuglik, Henrieta Greslikova, Renata Kupska, Pavel Nemec, Aneta Mikulasova, Iveta Valaskova, Jan Oppelt, Martina Almasi, Marta Krejci, Zdenek Adam, Ludek Pour, Roman Hájek ... other authors | |
| Year: 2016, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | |
| journal article | |
| Cytogenetics in multiple myeloma patients progressing into extramedullary disease | |
| Lenka Besse, Lenka Sedlarikova, Henrieta Greslíková, Renata Kupska, Martina Almasi, Miroslav Penka, Tomáš Jelínek, Luděk Pour, Zdeněk Adam, Petr Kuglik, Marta Krejci, Roman Hájek, Sabina Ševčíková ... other authors | |
| Year: 2016, EUR J HAEMATOL | |
| journal article | |
| Does AL amyloidosis have a unique genomic profile? Gene expression profiling meta-analysis and literature overview | |
| Fedor Kryukov, Elena Kryukova, Lucie Brožová, Zuzana Kufová, Jana Filipová, Kateřina Growková, Tereza Ševčíková, Jiří Jarkovský, Roman Hájek ... other authors | |
| Year: 2016, GENE | |
| journal article | |
| Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma | |
| Robert Z. Orlowski, Arnon Narger, Pieter Sonneveld, Joan Bladé, Roman Hájek, Andrew Spencer, Tadeusz Robak, Anna Dmoszynska, Noemi Horvath, Ivan Spicka, Heather J. Sutherland, Alexander N. Suvorov, Liang Xiu, Andrew Cakana, Trilok Parekh, Jesus F. San-Miguel ... other authors | |
| Year: 2016, CANCER | |
| journal article | |
| Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance | |
| Aneta Mikulášová, J. Smetana, M. Wayhelova, H. Janyskova, V. Sandecka, Zuzana Kufová, M. Almasi, J. Jarkovsky, E. Gregora, P. Kessler, M. Wrobel, B.A. Walker, CH. P. Wardell, G.J. Morgan, Roman Hájek, P. Kuglik ... other authors | |
| Year: 2016, EUR J HAEMATOL | |
| journal article | |
| Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma | |
| A. Keith Stewart, MeletiosA. Dimopoulos, Tamás Masszi, Ivan Špička, Albert Oriol, Roman Hájek ... other authors | |
| Year: 2016, J CLIN ONCOL | |
| journal article | |
| Chronická lymfocytární leukemie -současné možnosti léčby | |
| J. Zuchnická, J. Fečková Mihalyová, Roman Hájek | |
| Year: 2016, Remedia | |
| journal article | |
| Ibrutinib v hematoonkologii | |
| Jana Fečková Mihályová, Juraj Ďuraš, Jana Zuchnická, Michal Kaščák, Roman Hájek | |
| Year: 2016, Klinická Farmakologie a Farmacie | |
| journal article | |
| Immunomodulatory drugs in AL amyloidosis | |
| Tomáš Jelínek, Zuzana Kufová, Roman Hájek | |
| Year: 2016, CRIT REV ONCOL HEMAT | |
| journal article | |
| Léčba starší nemocné s chronickou lymfocytární leukemií kombinací obinutuzumab a chlorambucil. | |
| J. Zuchnická, J. Fečková Mihalyová, Roman Hájek | |
| Year: 2016, Acta medicinae | |
| journal article | |
| Monoclonal antibodies - A new era in the treatment of multiple myeloma. | |
| Tomáš Jelínek, Roman Hájek | |
| Year: 2016, Blood reviews | |
| journal article | |
| Nové inovativní léky v léčbě mnohočetného myelomu. | |
| Lenka Zahradová, Hana Plonková, Kristina Grácová, Roman Hájek | |
| Year: 2016, Remedia | |
| journal article | |
| Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma | |
| Valeria Magarotto, Sara Bringhen, Massimo Offidani, Giulia Benevolo, Francesca Patriarca, Roberto Mina, Antonietta Pia Falcone, Lorenzo De Paoli, Giuseppe Piatrantuono, Silvia Gentili, Caterina Musolino, Nicola Giuliani, Annalisa Bernardini, Concetta Conticello, Stefano Pulini, Giovannino Ciccone, Vladimír Maisnar, Marina Ruggeri, Renato Zambello, Tommasina Guglielmelli, Antonio Ledda, Anna Marina Liberati, Vittorio Montefusco, Roman Hájek, Mario Boccadoro, Antonio Palumbo ... other authors | |
| Year: 2016, BLOOD | |
| journal article | |
| Waldenströmova makroglobulinémie v roce 2016: optimalizace imunochemoterapie s cílem minimalizace nežádoucích účinků | |
| Michal Kaščák, Zuzana Kufová, Kateřina Growková, Roman Hájek | |
| Year: 2016, Onkologia pre prax | |
| journal article | |
| Whole genome amplification effect on segmental copy-number changes and copy-number neutral loss of heterozygosity analysis by oligonucleotide-based array-comparative genomic hybridization in human myeloma cell line | |
| Aneta Mikulášová, Jan Smetana, Markéta Wayhelová, Helena Janyskova, Samuel A Okubote, Roman Hájek, Petr Kuglik ... other authors | |
| Year: 2016, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | |
| journal article | |
| Analysis of B-cell subpopulations in monoclonal gammopathies | |
| Pavla Všianská, Lucie Říhová, Tamara Varmužová, Renata Suská, Fedor Kryukov, Aneta Mikulášová, Renata Kupská, Miroslav Penka, Luděk Pour, Zdeněk Adam, Roman Hájek ... other authors | |
| Year: 2015, Clinical Lymphoma, Myeloma and Leukemia | |
| journal article | |
| Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up | |
| Heinz Ludwig, Richard Greil, Tamas Masszi, Ivan Spicka, Ofer Shpilberg, Roman Hájek, Anna Dmoszynská, Bruno Paiva, María Belén Vidriales, Graca Esteves, Anne Marie Stoppa, Don Robinson, Jr., Shalini Chaturvedi, Ozlem Ataman, Christopher Enny, Huaibao Feng, Helgi van de Velde, Luisa Viterbo ... other authors | |
| Year: 2015, BRIT J HAEMATOL | |
| journal article | |
| Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma | |
| A.Keith Stewart,M.B., S. Vincent Rajkumar, Meletios A. Dimopoulos, Tamas Masszi, Ivan Špička, Ph.D., Albert Oriol, Roman Hájek, Laura Rosiňol, Ph.D, David S. Siegel, Georgi G. Mihaylov, Vesselina Giranova-Marinová, Péter Rajnics, Aleksandr Suvorov, Ruben Niesvizky, Andrej J. Jakubowiak, Jesus F. San-Miguel, Heinz Ludwig, Michael Wang, Vladimír Maisnar, Jiří Minařík, Wiliam I. Bensinger, Mária-Victoria Mateos, Dina Ben-Yehuda, Vishal Kukreti, Naseem Zojwalla, Margaret E. Tonda, Xinqun Yang, Biao Xing, Philippe Moreau, Antonio Palumbo ... other authors | |
| Year: 2015, NEW ENGL J MED | |
| journal article | |
| Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma | |
| Lenka Besse, Lenka Sedlaříková, Fedor Kryukov, Jana Nekvidová, Lenka Radová, Ondřej Slabý, Petr Kuglik, Martina Almasi, Miroslav Penka, Marta Krejčí, Zdeněk Adam, Luděk Pour, Sabina Ševčíková, Roman Hájek ... other authors | |
| Year: 2015, PLOS ONE | |
| journal article | |
| Combination of serum microRNA-320a and microRNA-320b as a marker for Waldenström macroglobulinemia | |
| Lenka Kubiczkova Besse, Lenka Sedlarikova, Fedor Kryukov, Jana Nekvindova, Lenka Radova, Martina Almasi, Jana Pelcova, Jiri Minarik, Tomas Pika, Zuzana Pikalova, Vlastimil Scudla, Marta Krejci, Zdenek Adam, Ludek Pour, Roman Hájek, Sabina Sevcikova ... other authors | |
| Year: 2015, American Journal of Hematology | |
| journal article | |
| Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma | |
| Antonio Palumbo, Francesca Gay, Federica Cavallo, Francesco Di Raimondo, Alessandra Larocca, Izhar Hardan, Arnon Nagler, Maria T. Petrucci, Roman Hájek, Sara Pezzatti, Michel Delforge, Francesca Patriarca, Francesca Donato, Chiara Cerrato, Chiara Nozzoli, Zhinuan Yu, Luana Boccadifuoco, Tommaso Caravita, Giulia Benevolo, Tommasina Guglielmelli, Donatella Vincelli, Christian Jacques, Meletios A. Dimopoulos, Giovannino Ciccone, Pellegrino Musto, Paolo Corradini, Michele Cavo, Mario Boccadoro ... other authors | |
| Year: 2015, J CLIN ONCOL | |
| journal article | |
| European Myeloma Network. European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications | |
| Evangelos Terpos, Martin Kleber, Monika Engelhardt, Sonja Zweegman, Francesca Gay, Efstathios Kastritis, Niels W.C.J. van de Donk, Benedetto Bruno, Orthan Sezer, Annemiek Broijl, Sara Bringhen, Meral Beksac, Alessandra Larocca, Roman Hájek, Pellegrino Musto, Hans Erik Johnsen, Fortunato Morabito, Heinz Ludwig, Michele Cavo, Hermann Einsele, Pieter Sonneveld, Meletion A. Dimopoulos, Antonio Palumbo ... other authors | |
| Year: 2015, HAEMATOL-HEMATOL J | |
| journal article | |
| Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data | |
| Sabina Ševčíková, Helena Paszeková, Lenka Besse, Lenka Sedlariková, Veronika Kubaczková, Martina Almasi, Luděk Pour, Roman Hájek ... other authors | |
| Year: 2015, BIOMEDICAL PAPERS-OLOMOUC | |
| journal article | |
| Flow cytometry in immunoglobulin light chain amyloidosis: Short review | |
| Jana Filipová, Lucie Řihová, Pavla Vsianská, Zuzana Kufová, Elena Kryukova, Fedor Kryukov, Roman Hájek ... other authors | |
| Year: 2015, LEUKEMIA RES | |
| journal article | |
| Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report | |
| Antonio Palumbo, Sara Bringhen, Maria-Victoria Mateos, Alessandra Larocca, Thierry Facon, Shaji K. Kumar, Massimo Offidani, Philip McCarthy, Andrea Evangelista, Sagar Lonial, Sonja Zweegman, Pellegrino Musto, Evangelos Terpos, Andrew Belch, Roman Hájek, Heinz Ludwig, A. Keith Stewart, Philippe Moreau, Kenneth Anderson, Hermann Einsele, Brian G. M. Durie, Meletios A. Dimopoulos, Ola Landgren, Jesus F. San Miguel, Paul Richardson, Pieter Sonneveld, S. Vincent Rajkumar ... other authors | |
| Year: 2015, BLOOD | |
| journal article | |
| Hereditární amyloidózy - etiologie, klinický obraz a léčba | |
| Zuzana Kufová, T. Pika, T. Jelínek, Fedor Kryukov, Roman Hájek | |
| Year: 2015, Transfuze a Hematologie Dnes | |
| journal article | |
| Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial | |
| Francesca Gay, Stefania Oliva, Maria Teresa Petrucci, Concetta Conticello, Lucio Catalano, Paolo Corradini, Agostina Siniscalchi, Valeria Magarotto, Ludek Pour, Angelo Carella, Alessandra Malfitano, Daniela Petro, Andrea Evangelista, Stefano Spada, Norbert Pescosta, Paola Omede, Philip Campbell, Anna Marina Liberati, Massimo Offidani, Roberto Ria, Stefano Pulini, Francesca Patriarca, Roman Hájek, Andrew Spencer, Mario Boccadoro, Antonio Palumbo ... other authors | |
| Year: 2015, LANCET ONCOL | |
| journal article | |
| MicroRNAs in urine are not biomarkers of multiple myeloma | |
| Lenka Sedlaříková, Lenka Bešše, Soňa Novosadová, Veronika Kubaczková, Lenka Radová, Michal Staník, Marta Krejčí, Roman Hájek, Sabina Ševčíková ... other authors | |
| Year: 2015, Journal of Negative Results in BioMedicine | |
| journal article | |
| Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma A Comparison with Real-Time PCR | |
| Daniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, Nadia Dani, Roberto Passera, Barbara Mantoan, Manuela Gambella, Luigia Monitillo, Elona Saraci, Paola Ghione, Elisa Genuardi, Daniela Barbero, Paola Omede, Davide Barberio, Roman Hájek, Umberto Vitolo, Antonio Palumbo, Sergio Cortelazzo, Mario Boccadoro, Giogio Inghirami, Marco Ladetto ... other authors | |
| Year: 2015, J MOL DIAGN | |
| journal article | |
| Plasma cell leukemia: from biology to treatment | |
| Tomáš Jelínek, Fedor Kryukov, Lucie Říhová, Roman Hájek | |
| Year: 2015, EUR J HAEMATOL | |
| journal article | |
| Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy | |
| Jiří Minarik, Petr Pavlicek, Luděk Pour, Tomáš Pika, Vladimír Maisnar, Ivan Spicka, Jiří Jarkovský, Marta Krejci, Jaroslav Bacovský, Jakub Radocha, Jan Straub, Petr Kessler, Marek Wrobel, Lenka Walterova, Michal Sykora, Jarmila Obernauerova, Lucie Brozova, Evzen Gregora, Dagmar Adamova, Jaromir Gumulec, Zdenek Adam, Vladimir Scudla, Roman Hájek ... other authors | |
| Year: 2015, PLOS ONE | |
| journal article | |
| Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance | |
| Lenka Kubiczkova, Fedor Kryukov, Ondrej Slaby, Elena Dementyeva, Jiri Jarkovsky, Jana Nekvindova, Lenka Radova, Henrieta Greslikova, Petr Kuglik, Eva Vetesnikova, Ludek Pour, Zdenek Adam, Sabina Sevcikova, Roman Hájek ... other authors | |
| Year: 2014, Haematologica | |
| journal article | |
| Detekce hereditárních amyloidóz | |
| Zuzana Kufová, Zuzana Ševčíková, Roman Hájek | |
| Year: 2014, Klinická biochemie a metabolismus | |
| journal article | |
| European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma | |
| Monika Engelhardt, Evangelos Terpos, Martina Kleber, Francesca Gay, Ralph Wäsch, Gareth Morgan, Michele Cavo, Niels van de Donk, Andreas Beilhack, Benedetto Bruno, Hans Erik Johnsen, Roman Hájek, Christoph Driessen, Heinz Ludwig, Meral Beksac, MArio Boccadoro, Christian Straka, Sara Brighen, Martin Gramatzki, Alessandra Larocca, Henk Lokhorst, Valeria Magarotto, Fortunato Morabito, Meletios A. Dimopoulos, Hermann Einsele, Pieter Sonneveld, Antonio Palumbo ... other authors | |
| Year: 2014, Haematologica | |
| journal article | |
| European Perspective on Multiple Myeloma Treatment Strategies in 2014 | |
| Heinz Ludwig, Pieter Sonneveld, Faith Davies, Joan Blade, Mario Boccadoro, Michele Cavo, Gareth Morgan, Javier de la Rubia, Michel Delforge, Meletios Dimopoulos, Hermann Einsele, Thierry Facon, Hartmut Goldschmidt, Philippe Moreau, Hareth Nahi, Torben Plesner, Jesus San-Miguel, Roman Hájek, Pia Sondergeld, Antonio Palumbo ... other authors | |
| Year: 2014, Oncologist | |
| journal article | |
| Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged >= 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial | |
| Meletios A. Dimopoulos, Antonio Palumbo, Roman Hájek, Martin Kropff, Maria Teresa Petrucci, Philip Lewis, Stefanie Millar, Jingshan Zhang, Jay Mei, Michel Delforge ... other authors | |
| Year: 2014, Leukemia & Lymphoma | |
| journal article | |
| Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience | |
| Jan Smetana, Jan Frohlich, Romana Zaoralova, Vladimira Vallova, Henrieta Greslikova, Renata Kupska, Pavel Nemec, Aneta Mikulasova, Martina Almasi, Ludek Pour, Zdenek Adam, Viera Sandecka, Lenka Zahradová, Roman Hájek, Petr Kuglik ... other authors | |
| Year: 2014, BIOMED RESEARCH INTERNATIONAL | |
| journal article | |
| Heterogenita a plasticita mnohočetného myelomu, aneb existuje skutečně myelomová kmenová buňka? | |
| H. Šváchová, S. Okubote, Roman Hájek | |
| Year: 2014 | |
| abstract in proceedings | |
| International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation | |
| Antonio Palumbo, S. Vincent Rajkumar, Jesus F. San Miguel, Alessandra Larocca, Ruben Niesvizky, Gareth Morgan, Ola Landgren, Roman Hájek, Hermann Einsele, Kenneth C. Anderson, Meletios A. Dimopoulos, Paul G. Richardson, Michele Cavo, Andrew Spencer, A. Keith Stewart, Kazuyuki Shimizu, Sagar Lonial, Pieter Sonneveld, Brian G.M. Durie, Philippe Moreau, Robert Z. Orlowski ... other authors | |
| Year: 2014, Journal of Clinical Oncology | |
| journal article | |
| International Myeloma Working Group recommendations for global myeloma care | |
| H. Ludwig, JS Miguel, MA Dimopoulos, A Palumbo, R Garcia Sanz, R Powles, S Lentzsch, W Ming Chen, J Hou, A Jurczyszyn, K Romeril, Roman Hájek, E Terpos, K Shimizu, D Joshua, V Hungria, A Rodriguez Morales, D Ben-Yehuda, P Sondergeld, E Zamagni, B Durie ... other authors | |
| Year: 2014, Leukemia | |
| journal article | |
| Management of Surgical Procedures in Patients with Inherited F VII Deficiency: Six Years of Experience | |
| Radomira Hrdlickova, Sarka Blahutova, Roman Hájek, Zuzana Čermáková | |
| Year: 2014, Journal of Blood Disorders & Transfusion | |
| journal article | |
| Nestin expression throughout multistep pathogenesis of multiple myeloma | |
| Hana Svachova, Fedor Kryukov, Elena Kryukova, Sabina Sevcikova, Pavel Nemec, Henrieta Greslikova, Lucie Rihova, Lenka Kubiczkova, Roman Hájek ... other authors | |
| Year: 2014, British Journal of Haematology | |
| journal article | |
| Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma | |
| Lenka Kubiczkova, Ludek Pour, Lenka Sedlarikova, Roman Hájek, Sabina Sevcikova | |
| Year: 2014, Journal of Cellular and Molecular Medicine | |
| journal article | |
| Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data | |
| Antonio Palumbo, Sara Bringhen, Shaji K. Kumar, Giulia Lupparelli, Saad Usmani, Anders Waage, Alessandra Larocca, Bronno van der Holt, Pellegrino Musto, Massimo Offidani, Maria T Petrucci, Andrea Evangelista, Sonja Zweegman, Ajay K Nooka, Andrew Spencer, Meletios A Dimopoulos, Roman Hájek, Michele Cavo, Paul Richardson, Sagar Lonial, Giovannino Ciccone, Mario Boccadoro, Kenneth Anderson, Bart Barlogie, Pieter Sonneveld, Philip L McCarthy ... other authors | |
| Year: 2014, LANCET ONCOL | |
| journal article | |
| Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse | |
| Ludek Pour, Sabina Sevcikova, Henrieta Greslikova, Renata Kupska, Petra Majkova, Lenka Zahradova, Viera Sandecka, Zdenek Adam, Marta Krejci, Petr Kuglik, Roman Hájek ... other authors | |
| Year: 2014, Haematologica | |
| journal article | |
| The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | |
| Niels W. C. J. van de Donk, Antonio Palumbo, Hans Erik Johnsen, Monika Engelhardt, Francesca Gay, Henrik Gregersen, Roman Hájek, Martina Kleber, Heinz Ludwig, Gareth Morgan, Pellegrino Musto, Torben Plesner, Orhan Sezer, Evangelos Terpos, Anders Waage, Sonja Zweegman, Hermann Einsele, Pieter Sonneveld, Henk M. Lokhorst ... other authors | |
| Year: 2014, Haematologica | |
| journal article | |
| The role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myeloma | |
| Roman Hájek, David Siegel, Robert Z. Orlowski, Heinz Ludwig, Antonio Palumbo, Meletios Dimopoulos ... other authors | |
| Year: 2014, Leukemia & Lymphoma | |
| journal article | |
| Využití imunomodulačních léků u amyloidózy | |
| Roman Hájek, Tomáš Jelínek | |
| Year: 2014, Mnohočetný myelom | |
| journal article | |
| Diagnostika a léčba systémové AL amyloidózy | |
| Vlastimil Ščudla, Zdeněk Adam, Roman Hájek, Marta Krejčí, Tomáš Pika, Vladimír Maisnar, Patrik Flodr, Zuzana KUFOVÁ, Pavla Látalová, Anna Potáčová, Romana Ryšavá, Ivan Špička, Martin Tichý, Pavla Všianská ... other authors | |
| Year: 2013, Transfuze a hematologie dnes | |
| journal article | |
| Mnohočetný myelom | |
| Roman Hájek, Hana Plonková, Tomáš Jelínek | |
| Year: 2013, Acta medicinae | |
| journal article | |
| Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma | |
| Roman Hájek, Samuel A. Okubote, Hana Svachova | |
| Year: 2013, BRIT J HAEMATOL | |
| journal article | |
| Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group | |
| C. Fernández de Larrea, R A. Kyle, B G M. Durie, H. Ludwig, S. Usmani, D H. Vesole, Roman Hájek, J F. San Miguel, O. Sezer, P. Sonneveld, S K. Kumar, A. Mahindra, R. Comenzo, A. Palumbo, A. Mazumber, K C. Anderson, P G. Richardson, A Z. Badros, J. Caers, M. Cavo, X. LeLeu, M A. Dimopoulos, C S. Chim, R. Schots, A. Noeul, D. Fantl, U-H. Mellqvist, O. Landgren, A. Chanan-Khan, P. Moreau, R. Fonseca, G. Merlini, J J. Lahuerta, J. Blade, R Z. Orlowski, J J. Shah ... other authors | |
| Year: 2013, LEUKEMIA | |
| journal article | |
| Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma | |
| Paul G. Richardson, Constantine S. Mitsiades, Jacob P. Laubach, Roman Hájek, Ivan Spicka, Meletios A. Dimopoulos, Philippe Moreau, David S. Siegel, Sundar Jagannath, Kenneth C. Anderson ... other authors | |
| Year: 2013, LEUKEMIA RES | |
| journal article | |
| Thalidomid v léčbě mnohočetného myelomu se zaměřením na kombinaci s bortezomibem | |
| Roman Hájek, Jaromír Gumulec | |
| Year: 2013, Klinická onkologie | |
| journal article | |
| Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study | |
| Meletios Dimopoulos, David S Siegel, Sagar Lonial, Junyuan Qi, Roman Hájek, Thierry Facon, Laura Rosinol, Catherine Williams, Hilary Blacklock, Hartmut Goldschmidt, Vania Hungia, Andrew Spencer, Antonio Palumbo, Thorsten Graef, Joseph E Eid, Jennifer Houp, Linda Sun, Scott Vuocolo, Kenneth C Anderson ... other authors | |
| Year: 2013, LANCET ONCOL | |
| journal article | |
| Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM) | |
| Roman Hájek, Richard Bryce, Sunhee Ro, Barbara Klencke, Heinz Ludwig | |
| Year: 2012, BMC CANCER | |
| journal article | |
| Kombinovaná léčba nemocných s mnohočetným myelomem - lenalidomid | |
| Roman Hájek, Hana Plonková | |
| Year: 2012, Acta Medicinae | |
| journal article | |
| Lenalidomide, melphalan, and prednisone followed by lenalidomide maintenance improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial | |
| M. A. Dimopoulos, M. Delforge, Roman Hájek, M. Kropff, MT Petrucci, P. Lewis, A. Nixon, J. Zhang, J. Mei, A. Palumbo ... other authors | |
| Year: 2012, Haematologica | |
| journal article | |
| Lenalidomid v dlouhodobé strategii léčby mnohočetného myelomu | |
| Hana Plonková, Tomáš Jelínek, Lenka Zahradová, Roman Hájek | |
| Year: , Mnohočetný myelom | |
| journal article | |
No record found.
| Author | Title | Type of thesis | Year |
|---|---|---|---|
| Jelínek Tomáš | Modern immunotherapy in the treatment of multiple myeloma and acute myeloid leukemia | Doctoral thesis | 2020 |
| Filipová Jana | Selection and separation of cells using flow cytometry with focusing on rare monoclonal gammapathies | Master's thesis | 2015 |
| Kočí Renáta | Options of inhibition of the mitotic spindle by modern medicaments in the blood cancer issue | Bachelor's thesis | 2016 |
| A novel local therapy for myeloma bone disease | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 5/2021 - 12/2024 |
| Provider | Ministerstvo zdravotnictví |
| State | solved |
| Molecular, cellular and clinical approach to healthy ageing | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 9/2018 - 6/2023 |
| Provider | Operační program Výzkum, vývoj a vzdělávání (OP VVV) |
| State | solved |
| WE ARE "OSTRAVSKÁ" = THE MODERN, INSPIRATIONAL AND ATTRACTIVE PLACE FOR QUALITY STUDY | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 5/2017 - 12/2022 |
| Provider | Rektorát, Operační program Výzkum, vývoj a vzdělávání (OP VVV) |
| State | solved |
| New Directions of Biomedical Research in the Ostrava Region | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 5/2019 - 12/2022 |
| Provider | Děkanát LF, Operační program Výzkum, vývoj a vzdělávání (OP VVV) |
| State | solved |
| Aberrant plasma cells clonal diversification in immunoglobulin light chain amyloidosis | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 5/2015 - 12/2019 |
| Provider | IGA MZd |
| State | finished |
| PRO-Ost | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 1/2017 - 10/2019 |
| Provider | Centrum excelence IT4Innovations, divize, Děkanát FSS, Děkanát FU, Děkanát LF, Děkanát PdF, Děkanát PřF, Rektorát, Univerzitní knihovna, Operační program Výzkum, vývoj a vzdělávání (OP VVV) |
| State | in sustainability |
| Bone Marrow Microenvironment in Multiple Myeloma: Application of 2D and 3D in vitro models using patient's specific IPSCs derived Mesenchymal Stem cells | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 8/2016 - 12/2017 |
| Provider | Katedra interních oborů, Projekty podporované z rozpočtu měst krajských úřadů |
| State | finished |
| Podpora přípravy klíčových projektů OU v operačních programech EU pro nové programovací období | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 1/2015 - 12/2015 |
| Provider | Rozvojové programy MŠMT |
| State | finished |
| Zahájení dlouhodobého výzkumu u monoklonálních gamapatií | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 12/2014 - 12/2015 |
| Provider | Lékařská fakulta, Projekty podporované z rozpočtu měst krajských úřadů |
| State | finished |
| Zavedení metody sekvenování nové generace (next generation sequencing) v rámci screeningu hereditárních amyloidóz v České republice/ Dotační titul 2 | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 9/2014 - 8/2015 |
| Provider | Lékařská fakulta, Přírodovědecká fakulta, Projekty podporované z rozpočtu měst krajských úřadů |
| State | finished |
| Dynamics of microRNA and cellfree DNA profiles during multiple myeloma progression | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 1/2014 - 12/2014 |
| Provider | Ostatní projekty ze zahr. prostředků |
| State | finished |
| Zavedení a využití metody separace jednotlivých buněk pomocí imunofluorescenčních metod a následné aplikace v hematoonkologii | |
|---|---|
| Main solver | prof. MUDr. Roman Hájek, CSc. |
| Period | 10/2013 - 12/2014 |
| Provider | Lékařská fakulta, Projekty podporované z rozpočtu měst krajských úřadů |
| State | finished |
